1 00:00:04,905 --> 00:00:07,875 LET'S GET STARTED. I'M JUN 2 00:00:07,875 --> 00:00:10,310 HUH FROM THE EXPERIMENTAL 3 00:00:10,310 --> 00:00:12,379 IMMUNOLOGY BRANCH OF THE NCI. IT 4 00:00:12,379 --> 00:00:16,216 IS REALLY MY GREAT PLEASURE TO 5 00:00:16,216 --> 00:00:17,751 WELCOME TODAY'S SPEAKER JUN HUH 6 00:00:17,751 --> 00:00:20,487 FOR HARVARD MEDICAL SCHOOL AND 7 00:00:20,487 --> 00:00:22,789 JUN RECEIVED HIS UNDERGRADUATE 8 00:00:22,789 --> 00:00:25,959 AND MASTERS DEGREE FROM SOLE 9 00:00:25,959 --> 00:00:29,162 NATIONAL UNIVERSITY IN KOREA. IN 10 00:00:29,162 --> 00:00:33,333 MICROBIOLOGY. SEAOUL. AFTERWARDS 11 00:00:33,333 --> 00:00:35,102 HE DECIDED TO MOVE EAST, 12 00:00:35,102 --> 00:00:36,970 CROSSING THE PACIFIC OCEAN 13 00:00:36,970 --> 00:00:38,939 LANDING IN CALIFORNIA AND DID 14 00:00:38,939 --> 00:00:41,642 HIS Ph.D. INCAL TECH. STUDYING 15 00:00:41,642 --> 00:00:44,177 DROSOPHILA AND THEN DECIDED TO 16 00:00:44,177 --> 00:00:47,915 MOVE UP AND GO TO VERTEBRATE AND 17 00:00:47,915 --> 00:00:49,683 LUCKILY FOR US IMMUNOLOGIST HE 18 00:00:49,683 --> 00:00:53,287 DID POST-DOCTORAL WORK MOVING 19 00:00:53,287 --> 00:00:57,024 AGAIN EAST IN NEW YORK AND DAN 20 00:00:57,024 --> 00:00:58,492 (INAUDIBLE) LAB HE DID 21 00:00:58,492 --> 00:00:59,526 PHENOMENAL WORK ON 22 00:00:59,526 --> 00:01:00,761 INTERLEUKIN-17 PRODUCING CELLS 23 00:01:00,761 --> 00:01:04,164 OR TH 17 CELLS. AND LOOKING AT 24 00:01:04,164 --> 00:01:06,300 TRANSCRIPTION FACTOR GAMMA T AND 25 00:01:06,300 --> 00:01:09,903 HOW IT IS REGULATED BY SMALL 26 00:01:09,903 --> 00:01:14,975 MOLECULE LIKE DINGOXIN. THEN 27 00:01:14,975 --> 00:01:17,945 DECIDED TO MOVE FURTHER EAST TO 28 00:01:17,945 --> 00:01:20,681 U MASS WORCESTER WHERE HE BECAME 29 00:01:20,681 --> 00:01:22,549 ASSISTANT PROFESSOR AND THEN GOT 30 00:01:22,549 --> 00:01:25,419 A BREAK THROUGH IN IMMUNOLOGY 31 00:01:25,419 --> 00:01:27,521 AND NEURAL DEVELOPMENT, THEY 32 00:01:27,521 --> 00:01:30,090 FOUND MATURE IL 17 IS REGULATING 33 00:01:30,090 --> 00:01:31,758 AUTISM, NEURAL DEVELOPMENT IN 34 00:01:31,758 --> 00:01:33,627 MICE AND THEN FURTHER FOUND OUT 35 00:01:33,627 --> 00:01:37,097 THE MICROBIOME TO INFLUENCE SIP 36 00:01:37,097 --> 00:01:39,266 1. PHENOMENALLY SUCCESSFUL THEN 37 00:01:39,266 --> 00:01:42,269 DECIDED TO MOVE EVEN MORE EAST 38 00:01:42,269 --> 00:01:44,604 AND NORTH, ENDED UP IN HARVARD 39 00:01:44,604 --> 00:01:46,039 WHERE HE IS NOW ASSOCIATE 40 00:01:46,039 --> 00:01:49,176 PROFESSOR. AND I HOPE HE'S NOT 41 00:01:49,176 --> 00:01:50,610 MOVING FURTHER BECAUSE THE ONLY 42 00:01:50,610 --> 00:01:55,115 OTHER PLACE TO GO IS NOVA 43 00:01:55,115 --> 00:01:58,185 SCONOVASCOTIA. SCIENTIFICALLY JS 44 00:01:58,185 --> 00:02:01,788 JUST PHENOMENAL. HE IS A 45 00:02:01,788 --> 00:02:03,090 FIELDIST AND PIONEERING AND 46 00:02:03,090 --> 00:02:05,726 TRAIL BLAZING PERSON. HE'S ALSO 47 00:02:05,726 --> 00:02:07,761 VERY SWEET AND NICE GUY AND I 48 00:02:07,761 --> 00:02:09,997 LOVE TO LISTEN TO HIS TALK. I 49 00:02:09,997 --> 00:02:11,598 LISTEN HIM LIKE A FEW TIMES AND 50 00:02:11,598 --> 00:02:13,400 ALWAYS AMAZED HOW HE DEVELOPED 51 00:02:13,400 --> 00:02:14,768 HIS STORY AND I HOPE YOU WILL 52 00:02:14,768 --> 00:02:17,004 ENJOY IT AS MUCH AS I DO. AND 53 00:02:17,004 --> 00:02:19,339 WITHOUT FURTHER ADIEU, WELCOME, 54 00:02:19,339 --> 00:02:26,413 JUN, TO THE NIH. 55 00:02:26,413 --> 00:02:29,483 >> THANK YOU VERY MUCH FOR THE 56 00:02:29,483 --> 00:02:35,088 KIND INTRODUCTION. I THINK I 57 00:02:35,088 --> 00:02:36,757 WILL MOVE EAST. THIS IS MY FIRST 58 00:02:36,757 --> 00:02:42,529 TIME TO THE SEMINAR AT NIH SO I 59 00:02:42,529 --> 00:02:45,198 THOUGHT BRIEFLY WHAT WE DO IN MY 60 00:02:45,198 --> 00:02:47,534 LAB AND THEN INITIALLY TELL YOU 61 00:02:47,534 --> 00:02:49,970 ABOUT PUBLISHED WORK SHOWING THE 62 00:02:49,970 --> 00:02:54,174 ROLE OF MICROMETABOLITE OF 63 00:02:54,174 --> 00:02:55,409 BIOLIPID, THIS IS ALL PUBLISHED 64 00:02:55,409 --> 00:02:58,345 SO GIVE YOU A SUMMARY THEN MOVE 65 00:02:58,345 --> 00:03:04,184 TO THE STORY TH 17 IN REGULATING 66 00:03:04,184 --> 00:03:05,886 NEURAL ACTIVITY. I WANT SHARE 67 00:03:05,886 --> 00:03:07,287 WITH YOU UNPUBLISHED WORK AS 68 00:03:07,287 --> 00:03:12,359 WELL. SO MANY OF YOU KNOW THIS 69 00:03:12,359 --> 00:03:17,297 IS A GRAPH BUT GRAPH ON YOUR 70 00:03:17,297 --> 00:03:20,167 RIGHT, COVID IS THE FIRST STORY 71 00:03:20,167 --> 00:03:25,238 BUT AS SOCIETY WE HAVEN'T DONE 72 00:03:25,238 --> 00:03:28,542 GOOD JOB, THE RATE HAVE BEEN 73 00:03:28,542 --> 00:03:32,813 OVER THE YEARS. LOOK AT GRAPH ON 74 00:03:32,813 --> 00:03:36,483 YOUR RIGHT, THOSE ARE VERY 75 00:03:36,483 --> 00:03:38,618 DIFFERENT IMAGE, THE PREVALENCE 76 00:03:38,618 --> 00:03:41,922 RATE OF MANY IMMUNE RELATED 77 00:03:41,922 --> 00:03:44,257 DISORDER AND FOR SOME REASON 78 00:03:44,257 --> 00:03:47,127 NOBODY KNOW FOR SURE IT HAS BEEN 79 00:03:47,127 --> 00:03:49,162 STUDIED ON THE STEADY RISE. I 80 00:03:49,162 --> 00:03:51,731 WANT TO SHOW YOU ANOTHER GRAPH 81 00:03:51,731 --> 00:03:53,700 WHICH IS PREVALENCE RATE OF 82 00:03:53,700 --> 00:03:55,068 NEUROLOGICAL DISORDERS SUCH AS 83 00:03:55,068 --> 00:03:57,170 AUTISM AND HERE YOU SEE DIRECTLY 84 00:03:57,170 --> 00:04:02,242 THE STEADY INCREASE OVER THE 85 00:04:02,242 --> 00:04:03,043 TRAINING YEAROR YEARS AND 86 00:04:03,043 --> 00:04:05,412 ACCORDING TO RECENT DATA CDC ONE 87 00:04:05,412 --> 00:04:07,214 OUT OF 36 CHILDREN BORN IN THE 88 00:04:07,214 --> 00:04:09,249 STATES ARE DIAGNOSED WITH AUTISM 89 00:04:09,249 --> 00:04:12,619 SPECTRUM DISORDER. SO 90 00:04:12,619 --> 00:04:14,754 ESSENTIALLY 30% OF CHILDREN TEND 91 00:04:14,754 --> 00:04:16,690 TO BE ON THIS SPECTRUM. WE CAN 92 00:04:16,690 --> 00:04:20,560 SPEND HOURS DISCUSSING ONE MAY 93 00:04:20,560 --> 00:04:22,028 UNDERLIE SUCH STEADY INCREASE 94 00:04:22,028 --> 00:04:25,398 BUT ONE THING THAT IS ABUNDANTLY 95 00:04:25,398 --> 00:04:31,905 CLEAR TO ME GENETIC MUTATION MAY 96 00:04:31,905 --> 00:04:34,141 NOT EXPLAIN ALONE, DIFFICULT TO 97 00:04:34,141 --> 00:04:36,443 IMAGINE MORE GENETIC MUTATION 98 00:04:36,443 --> 00:04:43,350 OVER PAST 20 YEARS YEARS. IMPORT 99 00:04:43,350 --> 00:04:44,451 ROLE OF THE ENVIRONMENTAL 100 00:04:44,451 --> 00:04:47,320 FACTORS NON-GENETIC FACTORS BUT 101 00:04:47,320 --> 00:04:50,690 WHAT THOSE FACTORS ARE ANOTHER 102 00:04:50,690 --> 00:04:52,492 TOPIC FOR DISCUSSION. BUT YOU 103 00:04:52,492 --> 00:04:55,262 MIGHT HAVE -- WE ARE FOCUSING ON 104 00:04:55,262 --> 00:04:58,131 PERHAPS IN MY MIND TWO MOST 105 00:04:58,131 --> 00:05:00,567 IMPORTANT NON-GENETIC FACTORS 106 00:05:00,567 --> 00:05:02,602 THAT CAN INFLUENCE HUMAN HEALTH. 107 00:05:02,602 --> 00:05:08,642 ONE IS MICROBIOME. AND WHAT 108 00:05:08,642 --> 00:05:13,680 HAPPENED DURING PREGNANCY. THIS 109 00:05:13,680 --> 00:05:16,049 IS A FACTOR THAT INFLUENCE FETUS 110 00:05:16,049 --> 00:05:18,285 AND CAN HAVE LONG TERM EFFECT IN 111 00:05:18,285 --> 00:05:22,822 OUR HEALTH. OVER THE YEARS MOST 112 00:05:22,822 --> 00:05:26,726 FOCUSING ON TWO FACTOR TRYING TO 113 00:05:26,726 --> 00:05:30,597 UNDERSTAND HOW THAT CAN 114 00:05:30,597 --> 00:05:32,299 INFLUENCE ANIMAL HEALTH MOSTLY 115 00:05:32,299 --> 00:05:34,734 MOUSE HEALTH. WE WILL BE FOCUS 116 00:05:34,734 --> 00:05:36,102 ON THE ROLE HAVING A SYSTEM IN 117 00:05:36,102 --> 00:05:39,239 THE MIDDLE. THIS IS THE SYSTEM 118 00:05:39,239 --> 00:05:42,576 IN INTERMEDIATE SIGNAL FROM THE 119 00:05:42,576 --> 00:05:43,310 MICROBIOME, REMEMBER WHAT 120 00:05:43,310 --> 00:05:45,245 HAPPENED IN PREGNANCY AND THOSE 121 00:05:45,245 --> 00:05:48,248 IMMUNE CELLS THAT INFLUENCE GUT 122 00:05:48,248 --> 00:05:49,115 HEALTH, ALSO IN A BRAIN 123 00:05:49,115 --> 00:05:51,318 FUNCTION. SO THAT'S WHAT TRUE 124 00:05:51,318 --> 00:05:54,888 ORGAN THAT MY LAB AND MOSTLY 125 00:05:54,888 --> 00:06:05,398 FOCUS ON. IN TERM OF CYTOKINE, 126 00:06:10,870 --> 00:06:13,206 IL 17, I DON'T NEED TO GIVE THE 127 00:06:13,206 --> 00:06:15,542 AUDIENCE INTERLEUKIN-17 IS 128 00:06:15,542 --> 00:06:16,610 HISTOROCK ILY KNOWN TO HAVE 129 00:06:16,610 --> 00:06:18,645 IMMUNE RELATED PROTECTING US 130 00:06:18,645 --> 00:06:20,580 FROM INVADING PATHOGENESIS, 131 00:06:20,580 --> 00:06:24,551 EXTRA CELL BACTERIA AND FUNGAL 132 00:06:24,551 --> 00:06:26,920 INFECTION BUT IL 17 IS SHOWN TO 133 00:06:26,920 --> 00:06:29,022 CONTRIBUTE TO DIFFERENT 134 00:06:29,022 --> 00:06:30,724 AUTOIMMUNE INFLAMMATORY DISORDER 135 00:06:30,724 --> 00:06:33,293 AND OUR WORK ALSO WORK FROM 136 00:06:33,293 --> 00:06:37,597 (INAUDIBLE) LAB SHOW THAT 137 00:06:37,597 --> 00:06:39,266 INTERLEUKIN 17 SHOW IMPACT ON 138 00:06:39,266 --> 00:06:40,400 NEURAL DEVELOPMENT AND FUNCTION 139 00:06:40,400 --> 00:06:42,235 AND NEURONAL REGENERATION OF 140 00:06:42,235 --> 00:06:48,842 INJURY. IMMUNE FUNCTION CAN BE 141 00:06:48,842 --> 00:06:54,447 INDUCED BY IL 17 AND PREVIOUSLY 142 00:06:54,447 --> 00:06:58,151 SHOWN, I WAS ABLE TO IDENTIFY 143 00:06:58,151 --> 00:06:59,619 MOLECULE WITH HORMONAL 144 00:06:59,619 --> 00:07:03,156 DIFFERENTIATION OF THE MOLECULE 145 00:07:03,156 --> 00:07:06,226 BUT BE SURE BY TRANSCRIPTION 146 00:07:06,226 --> 00:07:08,228 FACTOR RECEPTOR THAT SIT IN THE 147 00:07:08,228 --> 00:07:10,096 CONSERVATIVE'S SEAT AND CONTROL 148 00:07:10,096 --> 00:07:13,300 TH 17 PROGRAM AND ALSO SHOW 149 00:07:13,300 --> 00:07:14,234 (INAUDIBLE) CAN IMMUNOSUPPRESS 150 00:07:14,234 --> 00:07:17,037 THE FUNCTION OF GAMMA T AND TH 151 00:07:17,037 --> 00:07:20,640 17 CELLS. SO WE CAME IN 152 00:07:20,640 --> 00:07:22,976 WONDERING WHETHER THERE'S 153 00:07:22,976 --> 00:07:25,745 NATURAL LIGAND OR INHIBITOR OF 154 00:07:25,745 --> 00:07:28,515 TH 17 CELL THAT MAY ALSO BIND TO 155 00:07:28,515 --> 00:07:32,419 GAMMA T AND ALSO SUPPRESS 156 00:07:32,419 --> 00:07:34,421 SUPPRESS GAMMA CELL. WE 157 00:07:34,421 --> 00:07:36,022 HYPOTHESIZE WITH WACK TIERIA 158 00:07:36,022 --> 00:07:37,490 GAVE THE ABILITY TO CONTROL 159 00:07:37,490 --> 00:07:40,360 DEVELOPMENT OF FUNCTIONAL TH 17 160 00:07:40,360 --> 00:07:42,796 CELL BY PRODUCING SUCH A SMALL 161 00:07:42,796 --> 00:07:46,366 MOLECULE THAT CAN BIND TO GAMMA 162 00:07:46,366 --> 00:07:49,703 T. TO MAKE LONG STORY SHORT 163 00:07:49,703 --> 00:07:53,606 IDENTIFY METABOLITE WITH 164 00:07:53,606 --> 00:07:55,942 MODULATORY ACTIVITY WE DECIDE TO 165 00:07:55,942 --> 00:07:58,311 FOCUS ON BIOACIDACID. THE REASE 166 00:07:58,311 --> 00:08:00,647 FOCUS ON BIOACID IS AT THE TIME 167 00:08:00,647 --> 00:08:02,682 OTHER KNOWN GAMMA LIGAND WITH 168 00:08:02,682 --> 00:08:08,221 AGONISTIC OR ANTAGONISTIC 169 00:08:08,221 --> 00:08:10,690 ACTIVITY (INDISCERNIBLE) CORE 170 00:08:10,690 --> 00:08:12,359 CHOLESTEROL DERIVATIVE AND SOME 171 00:08:12,359 --> 00:08:14,894 OF YOU MAY KNOW DERIVED FROM 172 00:08:14,894 --> 00:08:17,797 CHOLESTEROL AND TONS OF VIRUSES 173 00:08:17,797 --> 00:08:20,133 ARE ABLE TO SEE IN OUR SYSTEM 174 00:08:20,133 --> 00:08:24,170 AND THE BIAS ARE SUBJECT TO THE 175 00:08:24,170 --> 00:08:30,176 MODIFICATION OF WHETHER THEY 176 00:08:30,176 --> 00:08:32,178 HAVE ABILITY TO CONTROL TH 17 177 00:08:32,178 --> 00:08:33,079 FUNCTION. THIS IS PUBLISHED 178 00:08:33,079 --> 00:08:34,981 WORK. SO I'M GOING TO GIVE YOU 179 00:08:34,981 --> 00:08:38,318 HIGHLIGHT OF THE STORY. WE 180 00:08:38,318 --> 00:08:41,254 WANTED TO KNOW IN VITRO SCREEN 181 00:08:41,254 --> 00:08:43,990 USING PRIMARY T-CELL CULTURE 182 00:08:43,990 --> 00:08:45,892 READ OUT WE USE A TH 17 183 00:08:45,892 --> 00:08:52,899 REGULATORY T-CELL, IDENTIFY TRUE 184 00:08:52,899 --> 00:08:56,169 BIAS, ACID DERIVATIVE, TH 17 185 00:08:56,169 --> 00:08:59,539 CELLS INHIBITED TH 17 CELL AND 186 00:08:59,539 --> 00:09:02,709 ENHANCE REGULATORY T-CELL IN 187 00:09:02,709 --> 00:09:06,513 VITRO. SO WHEN WE FIRST IDENTIFY 188 00:09:06,513 --> 00:09:11,718 THE SCA WE CONFIRM BIND TO HUMAN 189 00:09:11,718 --> 00:09:16,389 OLIGOBACTERIA IN VITRO WITH A 190 00:09:16,389 --> 00:09:20,226 MICROMOLAR. AND SUPPRESS 191 00:09:20,226 --> 00:09:23,763 TRANSCRIPTION ACTIVITY BECAUSE 192 00:09:23,763 --> 00:09:25,832 WHEN WE USE (INAUDIBLE) 193 00:09:25,832 --> 00:09:26,533 COEFFICIENT ACTIVITY AND 194 00:09:26,533 --> 00:09:29,436 MOREOVER IT IS SUPPRESS TH 17 195 00:09:29,436 --> 00:09:31,805 CELL DIFFERENTIATION WHEN WE ADD 196 00:09:31,805 --> 00:09:35,241 INTO THE IN VITRO CULTURE. 197 00:09:35,241 --> 00:09:40,280 RELATED TO THE CELLS ACID IN 198 00:09:40,280 --> 00:09:44,317 SUCH A PHENOTYPE IN VIVO WHEN WE 199 00:09:44,317 --> 00:09:47,220 ADMINISTER THE SINGLE MOUSE WITH 200 00:09:47,220 --> 00:09:49,422 (INAUDIBLE) WE ARE ABLE TO 201 00:09:49,422 --> 00:09:52,792 DETECT THIS, WE DO TH 17 202 00:09:52,792 --> 00:09:54,861 CHILDRENIATION, THIS IS A 203 00:09:54,861 --> 00:09:57,197 BACTERIA DEPENDENT TH 17 204 00:09:57,197 --> 00:09:59,265 DIFFERENTIATION MODEL. HOWEVER 205 00:09:59,265 --> 00:10:01,067 THE SAME (INAUDIBLE) REGULATORY 206 00:10:01,067 --> 00:10:04,170 T-CELL PERCENTAGE. THEN THIS IS 207 00:10:04,170 --> 00:10:05,405 THE FUN OF SCIENCE IN WAY WE 208 00:10:05,405 --> 00:10:07,841 WANT TO IDENTIFY BACTERIA OR 209 00:10:07,841 --> 00:10:10,176 BACTERIA ENZYME THAT PRODUCE TH 210 00:10:10,176 --> 00:10:12,545 17 MODULATORY BIOACID, WE 211 00:10:12,545 --> 00:10:16,549 COLLABORATED WITH OUR COLLEAGUE 212 00:10:16,549 --> 00:10:20,353 AT HMS AND BASICALLY SCREEN 213 00:10:20,353 --> 00:10:24,257 THOUSANDS OF HUMAN BACTERIA 214 00:10:24,257 --> 00:10:27,393 INDIVIDUALLY USING LCMS. AND 215 00:10:27,393 --> 00:10:31,030 BASED ON EACH WE INCLUDED THE 216 00:10:31,030 --> 00:10:34,033 INOCULATE ONE BACTERIA AND IN 217 00:10:34,033 --> 00:10:36,536 PREVIOUS AMINO ACID AS PRECURSOR 218 00:10:36,536 --> 00:10:38,972 MOLECULE AND THEN WE ARE ABLE TO 219 00:10:38,972 --> 00:10:43,710 IDENTIFY BACTERIA STRAIN THAT 220 00:10:43,710 --> 00:10:46,946 CONVERT ACETYLCHOLINE ACID. THIS 221 00:10:46,946 --> 00:10:50,383 IS THE TRUE FORCE SPEARHEADED BY 222 00:10:50,383 --> 00:10:51,751 (INDISCERNIBLE) FORMER POST DOC, 223 00:10:51,751 --> 00:10:55,522 WE ARE ABLE TO SUCCESSFULLY 224 00:10:55,522 --> 00:10:56,956 IDENTIFY BACTERIA AND BACTERIA 225 00:10:56,956 --> 00:11:00,093 ENZYME THAT CAN GENERATE THIS TH 226 00:11:00,093 --> 00:11:03,229 77 MODULATORY OR INHIBITOR 227 00:11:03,229 --> 00:11:06,032 BIOACID IN VITRO AND IN VIVO. IN 228 00:11:06,032 --> 00:11:08,902 TERMS OF HUMAN RELEVANCE WE 229 00:11:08,902 --> 00:11:10,803 COLLABORATED WITH (INAUDIBLE) IN 230 00:11:10,803 --> 00:11:18,478 OUR LAB, WE LOOK AT THE CELL TH 231 00:11:18,478 --> 00:11:21,514 INHIBITOR ASSAY, IN PATIENT WITH 232 00:11:21,514 --> 00:11:22,549 IGG PATIENT VERSUS HEALTHY 233 00:11:22,549 --> 00:11:24,517 CONTROL AND WE FOUND THIS IDD 234 00:11:24,517 --> 00:11:29,622 PATIENT WITH IDD THEY HAVE 235 00:11:29,622 --> 00:11:32,258 DEVELOP BACTERIA IN THEIR SYSTEM 236 00:11:32,258 --> 00:11:36,129 CONTROL, THIS IS CORRELATION BUT 237 00:11:36,129 --> 00:11:38,498 THAT DATA IS POSITIONED WITH OUR 238 00:11:38,498 --> 00:11:43,436 HYPOTHESIS, BACTERIAL IN TH 239 00:11:43,436 --> 00:11:45,638 FUNCTION AND PARTICIPATION, THEY 240 00:11:45,638 --> 00:11:47,307 MAY BE EXPOSED TO INFLAMMATION 241 00:11:47,307 --> 00:11:49,075 BECAUSE THEY DON'T HAVE AS MUCH 242 00:11:49,075 --> 00:11:51,511 MATERIAL CELLS IN THEIR SYSTEM. 243 00:11:51,511 --> 00:11:53,212 AND MOREOVER WHEN WE LOOK AT 244 00:11:53,212 --> 00:11:57,684 GENE EXPRESSION CHANGES WE FOUND 245 00:11:57,684 --> 00:11:59,652 IN CORRELATION BETWEEN LEVEL OF 246 00:11:59,652 --> 00:12:02,522 HCA AND EXPRESSION OF TH 17 SUCH 247 00:12:02,522 --> 00:12:06,059 AS IL 17 SO SUGGESTING EVEN IN 248 00:12:06,059 --> 00:12:08,861 HUMAN THE LEVEL OF MATERIAL 249 00:12:08,861 --> 00:12:13,166 CELLS MAY BE CORRELATED WITH TH 250 00:12:13,166 --> 00:12:15,101 17 PROGRAM. SO FROM ALL THIS 251 00:12:15,101 --> 00:12:17,270 DATA WE ARE ABLE TO FIND 252 00:12:17,270 --> 00:12:18,838 PARTICULAR BIAS AND PARTICULAR 253 00:12:18,838 --> 00:12:21,574 TYPES OF BACTERIA IN THE GUT, 254 00:12:21,574 --> 00:12:24,177 THEY CAN CONVERT THIS BACTERIA 255 00:12:24,177 --> 00:12:27,680 CAN CONVERT THE INKNOCK LOUSE 256 00:12:27,680 --> 00:12:30,817 BIAS SUCH AS ACETYLCHOLINE ASHED 257 00:12:30,817 --> 00:12:33,386 AND T-CELL INTO TH 17 OR T 258 00:12:33,386 --> 00:12:36,823 MODULATORY BIOASSAY AND THIS 259 00:12:36,823 --> 00:12:40,760 BACTERIA GENERATED SMALL 260 00:12:40,760 --> 00:12:43,796 MOLECULE BIOACID CUP INFLUENCE 261 00:12:43,796 --> 00:12:46,132 SYSTEM BY DIRECTLY INTERACTING 262 00:12:46,132 --> 00:12:47,567 WITH IN THIS CASE IN VITRO HOST 263 00:12:47,567 --> 00:12:49,469 TRANSCRIPTION FACTOR AND IN 264 00:12:49,469 --> 00:12:51,804 DOING SO MAY IMMUNOSUPPRESS 265 00:12:51,804 --> 00:12:53,606 INFLAMMATION. LIKEWISE, 266 00:12:53,606 --> 00:12:55,174 DIFFERENT TYPES OF BIAS, I 267 00:12:55,174 --> 00:12:56,843 DIDN'T HAVE TIME TO TALK ABOUT 268 00:12:56,843 --> 00:12:59,746 THIS BUT ANOTHER BIAS REGULATORY 269 00:12:59,746 --> 00:13:03,850 T-CELL DIFFERENTIATION MOSTLY IN 270 00:13:03,850 --> 00:13:08,054 VIVO, IN THIS CASE RECEPTOR, WE 271 00:13:08,054 --> 00:13:11,557 DO NOT CARE ABOUT -- THIS BIAS 272 00:13:11,557 --> 00:13:13,259 WITHIN (INAUDIBLE) BUT SHOWING 273 00:13:13,259 --> 00:13:19,766 AN EXAMPLE OF HOW BACTERIA 274 00:13:19,766 --> 00:13:22,001 UTILIZE THE HOST BACTERIA 275 00:13:22,001 --> 00:13:23,436 MODIFYING THEM AND CONTROLLING 276 00:13:23,436 --> 00:13:29,809 IMMUNE RESPONSES. AROUND THE 277 00:13:29,809 --> 00:13:30,877 SAME TIME (INDISCERNIBLE) IN 278 00:13:30,877 --> 00:13:35,915 JAPAN, THEY COMPARED BIAS IN THE 279 00:13:35,915 --> 00:13:39,919 CENTRAL AREA, PEOPLE WHO LIVE 280 00:13:39,919 --> 00:13:41,788 OVER 100 YEARS OLD VERSUS 281 00:13:41,788 --> 00:13:45,725 HEALTHY 80 YEARS OLD PEOPLE AND 282 00:13:45,725 --> 00:13:47,326 FOUND WHY (INAUDIBLE) IS 283 00:13:47,326 --> 00:13:49,162 COMPARABLE THEY FOUND OLDER 284 00:13:49,162 --> 00:13:52,298 IMMUNE MODULATORY BIAS WE 285 00:13:52,298 --> 00:13:56,269 IDENTIFY IN THE SENNARYIANS HAVE 286 00:13:56,269 --> 00:13:59,072 HIGHER IMMUNOMODULATORY BIAS 287 00:13:59,072 --> 00:14:00,873 THEIR GUT. THIS DATA DOESN'T 288 00:14:00,873 --> 00:14:02,775 MEAN THIS BILE ACID CAN MAKE 289 00:14:02,775 --> 00:14:04,677 THESE PEOPLE LIVE LONGER BUT 290 00:14:04,677 --> 00:14:06,646 AGAIN, PERHAPS THERE'S SOME 291 00:14:06,646 --> 00:14:07,580 CONNECTION CONTRIBUTION OF THIS 292 00:14:07,580 --> 00:14:10,383 IMMUNE MODULATORY BIAS AND THEIR 293 00:14:10,383 --> 00:14:12,285 HEALTH. JUST GOING TO GIVE YOU A 294 00:14:12,285 --> 00:14:13,219 BRIEF OVERVIEW OF THE TYPE OF 295 00:14:13,219 --> 00:14:15,088 WORK WE ARE DOING IN KIND OF 296 00:14:15,088 --> 00:14:17,557 STUDYING THE RELATIVE 297 00:14:17,557 --> 00:14:18,791 INTERESTING BETWEEN GUT BACTERIA 298 00:14:18,791 --> 00:14:20,493 AND IMMUNE CELL IN THE PERIPHERY 299 00:14:20,493 --> 00:14:21,961 AND THE CONTEXT OF GUT 300 00:14:21,961 --> 00:14:24,097 INFLAMMATION. NOW I WANT TO 301 00:14:24,097 --> 00:14:27,967 CHANGE GEAR AND TELL YOU 302 00:14:27,967 --> 00:14:30,503 DIFFERENT STORY, BETWEEN IMMUNE 303 00:14:30,503 --> 00:14:32,371 CELLS AND THE BRAIN. THE CELLS 304 00:14:32,371 --> 00:14:34,741 IN THE BRAIN. FOR THIS WORK WE 305 00:14:34,741 --> 00:14:37,243 DID COLLABORATE WITH GLORIA 306 00:14:37,243 --> 00:14:45,218 NEUROSCIENTIST AT MIT. AND WE 307 00:14:45,218 --> 00:14:46,986 DID HERE SO IF YOU HAVE A 308 00:14:46,986 --> 00:14:48,387 DIFFICULT QUESTION JUST WAIT AND 309 00:14:48,387 --> 00:14:53,526 ASK HER THOSE QUESTIONS, OKAY? I 310 00:14:53,526 --> 00:14:56,763 WANT TO ALSO BEFORE I GET INTO 311 00:14:56,763 --> 00:14:58,231 THIS, CANCER IMMUNOTHERAPY THIS 312 00:14:58,231 --> 00:15:01,367 IS ONE FINDING THAT REALLY 313 00:15:01,367 --> 00:15:03,903 CHANGED THE FIELD THE WAY WE 314 00:15:03,903 --> 00:15:06,706 TREAT CANCER PATIENTS. AND THEN 315 00:15:06,706 --> 00:15:08,841 BASICALLY THIS IS A WAY TO THIS 316 00:15:08,841 --> 00:15:11,110 IS HARNESSING OUR OWN IMMUNE 317 00:15:11,110 --> 00:15:13,045 SYSTEM AND IN DOING SO PEOPLE 318 00:15:13,045 --> 00:15:16,916 ARE ABLE TO RESTORE RE-ESTABLISH 319 00:15:16,916 --> 00:15:18,885 BALANCE, MAINTAIN THIS BALANCE. 320 00:15:18,885 --> 00:15:21,154 SO THE REASON WHY I MENTION THIS 321 00:15:21,154 --> 00:15:23,289 IS BECAUSE MY DREAM IS THAT 322 00:15:23,289 --> 00:15:25,591 PERHAPS SOME DAY WE MAYBE ABLE 323 00:15:25,591 --> 00:15:30,163 TO UTILIZE A SIMILAR APPROACH 324 00:15:30,163 --> 00:15:31,798 BECAUSE THE SYSTEM SYSTEM 325 00:15:31,798 --> 00:15:35,168 BASICALLY BALANCED, WHEN THINGS 326 00:15:35,168 --> 00:15:37,937 GO AWRY THEY CAN GET DEPLOYED TO 327 00:15:37,937 --> 00:15:41,641 DIFFERENT TISSUE. AND RESTORE 328 00:15:41,641 --> 00:15:42,875 HOMEOPATHIC BALANCE, THAT IS HOW 329 00:15:42,875 --> 00:15:44,977 WE ARE DOING IN THE SYSTEM TO 330 00:15:44,977 --> 00:15:47,980 SOME DAY IN THE FUTURE I HOPE 331 00:15:47,980 --> 00:15:52,618 THAT WE MAY BE ABLE TO SEE NOVEL 332 00:15:52,618 --> 00:15:55,221 IMMUNOTHERAPY THAT CAN BE USED 333 00:15:55,221 --> 00:15:59,292 TO TREAT AND TRAIN DISORDER, 334 00:15:59,292 --> 00:16:01,327 THAT'S WHEY I INCLUDE THAT. LIKE 335 00:16:01,327 --> 00:16:04,230 MANY OTHER GOOD IDEAS, YOU ARE 336 00:16:04,230 --> 00:16:05,898 NOT FIRST ONE TO THINK ABOUT SO 337 00:16:05,898 --> 00:16:07,500 THIS IS IMMUNOTHERAPY FOR 338 00:16:07,500 --> 00:16:08,734 NEUROLOGICAL DISORDERS. IT HAS 339 00:16:08,734 --> 00:16:12,805 BEEN USED BEFORE. SO SOMETIME 340 00:16:12,805 --> 00:16:15,575 AGO PEOPLE WANTED TO TRANSFER 341 00:16:15,575 --> 00:16:17,410 THIS AWESOME POWER OF 342 00:16:17,410 --> 00:16:19,345 INFLAMMATION AND THEY WANT TO -- 343 00:16:19,345 --> 00:16:22,014 BY TRANSFERRING THIS 344 00:16:22,014 --> 00:16:25,284 INFLAMMATION THEY WANT TO TREAT 345 00:16:25,284 --> 00:16:28,888 PSYCHIATRIC PATIENTS AND 346 00:16:28,888 --> 00:16:30,556 POTENTIALLY DRAWING PLOT IN A 347 00:16:30,556 --> 00:16:32,391 PATIENT THAT INFECTD WITH 348 00:16:32,391 --> 00:16:35,394 MALARIA AND BY TRANSFERRING THAT 349 00:16:35,394 --> 00:16:37,296 BLOOD INTO (INAUDIBLE) PATIENT 350 00:16:37,296 --> 00:16:41,500 THEY WANTED TO CURE THAT 351 00:16:41,500 --> 00:16:47,139 SYMPTOM. APPARENTLY THIS 352 00:16:47,139 --> 00:16:50,509 APPROACH WE EASILY TEND TO 353 00:16:50,509 --> 00:16:53,846 IMAGINE GOOD PRESENCE OF 354 00:16:53,846 --> 00:16:57,283 PATIENTS IN THIS NEW -- THE 355 00:16:57,283 --> 00:16:59,285 ARTIFACT, IMMUNE ACTIVATION. 356 00:16:59,285 --> 00:17:00,453 ALTERNATIVELY THIS APPROACH MUST 357 00:17:00,453 --> 00:17:02,855 HAVE BEEN SUCCESSFUL TO SOME 358 00:17:02,855 --> 00:17:07,627 DEGREE BECAUSE THE HISTORY 1927 359 00:17:07,627 --> 00:17:09,695 NOBEL PRIZE WAS GIVEN FOR 360 00:17:09,695 --> 00:17:11,464 THERAPY OF MALARIA INOCULATION 361 00:17:11,464 --> 00:17:13,566 IN TREATING CERTAIN FORM OF 362 00:17:13,566 --> 00:17:16,035 DEMENTIA. SO THIS IMMUNE -- 363 00:17:16,035 --> 00:17:20,172 NEURAL IMAGING, IS NOTHING NE N. 364 00:17:20,172 --> 00:17:24,844 THE FAST FORWARD IF YOU LOOK AT 365 00:17:24,844 --> 00:17:27,380 THIS PHENOMENON, I BRIEFLY 366 00:17:27,380 --> 00:17:28,748 INTRODUCED INCREASING RATE 367 00:17:28,748 --> 00:17:32,285 PREVALENCE RATE OF AUTISM BUT 368 00:17:32,285 --> 00:17:34,520 AMONG THIS PARAMOUNT (INAUDIBLE) 369 00:17:34,520 --> 00:17:36,556 CHILDREN THEY NOTED THAT WHEN 370 00:17:36,556 --> 00:17:37,924 THEY ARE CHILDREN WERE EXPOSED 371 00:17:37,924 --> 00:17:43,229 TO INFLAMMATION CERTAIN 372 00:17:43,229 --> 00:17:45,264 PERCENTAGE OF CHILDREN WITH 373 00:17:45,264 --> 00:17:46,966 AUTISM THEIR SYMPTOM, TALKING 374 00:17:46,966 --> 00:17:49,402 ABOUT THEIR CORE SYMPTOM, WHICH 375 00:17:49,402 --> 00:17:54,407 IS ASSOCIATED WITH (INAUDIBLE) 376 00:17:54,407 --> 00:17:55,775 BEHAVIOR THEIR (INAUDIBLE) 377 00:17:55,775 --> 00:17:58,244 IMPROVED. THIS IS IS SO CALLED 378 00:17:58,244 --> 00:18:01,547 FEVER EFFECT. SO FEVER EFFECT 379 00:18:01,547 --> 00:18:04,817 WHEN CHILDREN HAVE A FEVER THEIR 380 00:18:04,817 --> 00:18:06,185 SYMPTOM GET (INDISCERNIBLE) 381 00:18:06,185 --> 00:18:08,421 DRAMATICALLY IMPROVE. THIS IS AN 382 00:18:08,421 --> 00:18:10,222 ARTICLE I BROUGHT HERE AND MORE 383 00:18:10,222 --> 00:18:13,392 RECENT STUDY THEY LOOK AT MORE 384 00:18:13,392 --> 00:18:14,760 THAN 200 CHILDREN WITH AUTISM 385 00:18:14,760 --> 00:18:18,698 AND ACCORDING TO THIS STUDY 17% 386 00:18:18,698 --> 00:18:22,335 OF THESE CHILDREN THEY SHOW 387 00:18:22,335 --> 00:18:24,670 PEOPLE VISITATION OF AUTISM 388 00:18:24,670 --> 00:18:27,139 RELATED SYMPTOM. THEY SAY 389 00:18:27,139 --> 00:18:29,141 INTERESTING AND WEIRD. AUTISM IS 390 00:18:29,141 --> 00:18:32,778 LIKE A NEURAL DEVELOPMENT 391 00:18:32,778 --> 00:18:35,014 DISORDER BUT CORE SYMPTOM 392 00:18:35,014 --> 00:18:37,249 IMPROVED WHEN THEY IMPROVED 393 00:18:37,249 --> 00:18:38,584 INFLAMMATION. SO BASED ON THIS 394 00:18:38,584 --> 00:18:42,021 STUDY, ANOTHER STUDY ARTICLE 395 00:18:42,021 --> 00:18:43,589 SHOWING PEOPLE WITH BEHAVIOR 396 00:18:43,589 --> 00:18:45,858 PROBLEM IN SOME CHILDREN WITH 397 00:18:45,858 --> 00:18:47,660 AUTISM, AND SOME VARIATION STUDY 398 00:18:47,660 --> 00:18:51,063 TO STUDY VARIATION. I THINK 399 00:18:51,063 --> 00:18:52,398 SOMEWHERE BETWEEN 70% OF 400 00:18:52,398 --> 00:18:57,370 CHILDREN WITH AUTISM SHOW FEVER 401 00:18:57,370 --> 00:19:00,139 MITIGATION. ANOTHER STUDY WITH 402 00:19:00,139 --> 00:19:02,708 6% OF CHILDREN, I THINK 403 00:19:02,708 --> 00:19:10,649 SOMEWHERE BETWEEN LIKE 6 TO 17%, 404 00:19:10,649 --> 00:19:12,318 NOBODY KNOW FOR SURE THE FACTOR 405 00:19:12,318 --> 00:19:14,253 IN THE PHENOTYPE, MY LAB WE ARE 406 00:19:14,253 --> 00:19:16,989 TRYING TO INITIATE HUMAN STUDY. 407 00:19:16,989 --> 00:19:22,561 WE ARE COLLABORATING WITH 408 00:19:22,561 --> 00:19:26,565 AUTISTIC -- WE ARE GOING TO 409 00:19:26,565 --> 00:19:30,036 START TO IDENTIFY IMMUNE 410 00:19:30,036 --> 00:19:31,537 CORRELATES POSITIVELY OR 411 00:19:31,537 --> 00:19:32,438 NEGATIVELY ASSOCIATED WITH A 412 00:19:32,438 --> 00:19:35,975 FEVER. SO HOPEFULLY IF THERE IS 413 00:19:35,975 --> 00:19:39,178 A CHANCE IN A FEW YEARS I CAN 414 00:19:39,178 --> 00:19:44,617 SHARE IT WITH YOU MORE EXCITING 415 00:19:44,617 --> 00:19:50,556 FINDIFINDIFINDING. BASED ORANGEN 416 00:19:50,556 --> 00:19:51,924 OBSERVATION WE DECIDED TO USE 417 00:19:51,924 --> 00:19:55,327 MOUSE MODEL FOR AWETISM AND THEN 418 00:19:55,327 --> 00:19:56,462 TRY TO UNDERSTAND AUTISM AND TRY 419 00:19:56,462 --> 00:20:00,166 TO UNDERSTAND THE UNDERLYING 420 00:20:00,166 --> 00:20:01,734 MECHANISM THAT IMPROVE I BELIEVE 421 00:20:01,734 --> 00:20:04,870 FLAYMATION ASSOCIATED WITH -- 422 00:20:04,870 --> 00:20:06,739 THIS WAS PUBLISHED AWARD BUT IN 423 00:20:06,739 --> 00:20:08,307 ORDER TO STUDY THAT WE FIRST 424 00:20:08,307 --> 00:20:14,647 NEED TO USE A MOUSE MODEL IN 425 00:20:14,647 --> 00:20:19,151 AUTISM THERE'S NO BIOMARKER 426 00:20:19,151 --> 00:20:22,555 ESSENTIALLY A PHENOTYPIC BASIS 427 00:20:22,555 --> 00:20:24,690 STUDY SCIENTISTS GENERATE MANY 428 00:20:24,690 --> 00:20:26,892 REFER TO AUTISM MODEL, SOME 429 00:20:26,892 --> 00:20:28,694 REQUIRE GENETIC MUTATION. OTHER 430 00:20:28,694 --> 00:20:30,029 AUTISM MODEL DEPENDENT ON 431 00:20:30,029 --> 00:20:31,497 ENVIRONMENTAL FACTOR AND ONE 432 00:20:31,497 --> 00:20:34,834 MODEL THAT WE OFTEN USE IS HUMAN 433 00:20:34,834 --> 00:20:36,869 ACTIVATION MODEL. THIS IS A VERY 434 00:20:36,869 --> 00:20:42,374 -- THIS MODEL IS BASED ON HUMAN 435 00:20:42,374 --> 00:20:45,644 EPIDEMIOLOGICAL STUDY. IN 436 00:20:45,644 --> 00:20:46,912 RESPONSE TO SOME INFLAMMATION 437 00:20:46,912 --> 00:20:50,349 DURING PREGNANCY. SECOND 438 00:20:50,349 --> 00:20:52,718 TRIMESTER, LATE FIRST TRIMESTER 439 00:20:52,718 --> 00:20:55,287 PREGNANCY. THEIR CHILDREN HAVE A 440 00:20:55,287 --> 00:20:57,289 CHANCE TO DEVELOP 441 00:20:57,289 --> 00:20:58,324 NEURODEVELOPMENTAL DISORDER 442 00:20:58,324 --> 00:20:59,792 SIGNIFICANT INCREASE SO THIS IS 443 00:20:59,792 --> 00:21:10,269 AN APPROVAL REPORTED AGAIN, 444 00:21:10,703 --> 00:21:13,839 STUDY IN DENMARK, THEY HAD THIS 445 00:21:13,839 --> 00:21:16,775 STUDY IN DENMARK SINCE 1980, A 446 00:21:16,775 --> 00:21:19,011 WOMAN HOSPITALIZED DURING 447 00:21:19,011 --> 00:21:20,679 PREGNANCY, CHILDREN -- A CHANCE 448 00:21:20,679 --> 00:21:24,083 TO DEVELOP AUTISM SIGNIFICANTLY 449 00:21:24,083 --> 00:21:26,285 INCREASE. SO WE UTILIZE THIS 450 00:21:26,285 --> 00:21:27,620 MODEL IN MICE DURING PREGNANCY 451 00:21:27,620 --> 00:21:31,190 WE GIVE THEM INFLAMMATION, 452 00:21:31,190 --> 00:21:35,961 INJECT THEM WITH POLYIC AND 453 00:21:35,961 --> 00:21:39,598 LIGAND AND COMPARABLE TO HUMAN 454 00:21:39,598 --> 00:21:42,902 SECOND TRIMESTER OR LATE FIRST 455 00:21:42,902 --> 00:21:48,908 TRIMESTER. AND THEN -- LED WAIT 456 00:21:48,908 --> 00:21:52,711 TWO MONTHS, THEIR OFF SPRING 457 00:21:52,711 --> 00:21:55,114 (INAUDIBLE) COMPARE TO OFFSPRING 458 00:21:55,114 --> 00:21:59,451 PREVIOUS INJECTION TO THE MOTHER 459 00:21:59,451 --> 00:22:03,455 THEY SHOW INCREASE BEHAVIOR, 460 00:22:03,455 --> 00:22:05,024 SHOW (INAUDIBLE) SO OF COURSE 461 00:22:05,024 --> 00:22:06,025 NOBODY KNOW FOR SURE WHETHER 462 00:22:06,025 --> 00:22:09,395 THESE MICE ARE AUTISTIC BUT WE 463 00:22:09,395 --> 00:22:14,900 CAN SAY THESE MICE DURING 464 00:22:14,900 --> 00:22:16,001 PREGNANCY MANY MONTHS LATER 465 00:22:16,001 --> 00:22:17,136 THERE'S BEHAVIOR CHANGES SO 466 00:22:17,136 --> 00:22:20,072 USING THIS MOUSE MODEL WE WANT 467 00:22:20,072 --> 00:22:22,908 TO TEST WHETHER THIS MICE MODEL, 468 00:22:22,908 --> 00:22:26,579 WHEN THIS MOUSE SHOWING AUTISM 469 00:22:26,579 --> 00:22:29,081 LIKE BEHAVIOR WHEN THEY REACH 470 00:22:29,081 --> 00:22:30,182 (INAUDIBLE). WHAT HAPPEN IF WE 471 00:22:30,182 --> 00:22:32,418 GIVE THEM TO ANOTHER IMMUNE 472 00:22:32,418 --> 00:22:34,553 STIMULUS, RIGHT? SO COMPLICATED, 473 00:22:34,553 --> 00:22:39,024 RIGHT? SO INFLAMMATION DURING 474 00:22:39,024 --> 00:22:40,426 PREGNANCY CAN PROMOTE AUTISM 475 00:22:40,426 --> 00:22:43,862 BEHAVIOR. WE ARE ASKING THAT 476 00:22:43,862 --> 00:22:48,200 INFLAMMATION ONCE THE CIRCUIT IS 477 00:22:48,200 --> 00:22:49,168 COMPLETELY ESTABLISHED WHETHER 478 00:22:49,168 --> 00:22:52,404 THAT INFLAMMATION CAN MITIGATE 479 00:22:52,404 --> 00:22:54,406 BEHAVIOR SYMPTOM THAT IS WHAT WE 480 00:22:54,406 --> 00:22:59,211 DECIDED TO ASK. SOME MAY NOT BE 481 00:22:59,211 --> 00:23:00,579 FAMILIAR WITH BEHAVIOR STUDY, 482 00:23:00,579 --> 00:23:02,481 THIS IS A WIDELY ESTABLISHED 483 00:23:02,481 --> 00:23:04,516 MODEL BY IMMUNE BIOLOGIST, 484 00:23:04,516 --> 00:23:06,352 CONTROL MICE WAS GIVEN A CHOICE, 485 00:23:06,352 --> 00:23:09,388 THIS MOUSE SPEND MORE TIME WITH 486 00:23:09,388 --> 00:23:12,057 THEIR SOCIAL TARGET INSTEAD OF 487 00:23:12,057 --> 00:23:13,092 SPENDING TIME (INAUDIBLE) FOR 488 00:23:13,092 --> 00:23:15,728 DURATION OF 10 TO 15 MINUTES WE 489 00:23:15,728 --> 00:23:18,998 SHIFT THE MOUSE AND BY 490 00:23:18,998 --> 00:23:21,400 QUANTIFYING RELATIVE TIME SPENT 491 00:23:21,400 --> 00:23:25,004 IN ASSOCIATED TARGETS IN TARGET 492 00:23:25,004 --> 00:23:27,273 WE CAN QUANTIFY THE SOCIAL 493 00:23:27,273 --> 00:23:29,074 OPPORTUNITY THERE. SO 494 00:23:29,074 --> 00:23:30,876 ESTABLISHED STUDY, THAT IS WHAT 495 00:23:30,876 --> 00:23:32,344 BUT YOU SEE FROM THE CONTROL 496 00:23:32,344 --> 00:23:33,279 MICE. WHAT HAPPENED IF YOU DO 497 00:23:33,279 --> 00:23:37,483 THE SAME EXPERIMENT WITH THE 498 00:23:37,483 --> 00:23:39,952 MICE, P POSED TO INFLAMMATION IN 499 00:23:39,952 --> 00:23:42,087 MICE DURING PREGNAN PREGNANCY. T 500 00:23:42,087 --> 00:23:43,622 INTEREST IN SOCIAL TARGET. THEY 501 00:23:43,622 --> 00:23:45,190 SPEND EQUAL AMOUNT BETWEEN TWO 502 00:23:45,190 --> 00:23:47,059 TARGET BUT OVERALL THEY ARE 503 00:23:47,059 --> 00:23:50,329 MOVING DISTANCE, THEY ARE 504 00:23:50,329 --> 00:23:51,230 INVESTIGATION TIME ARE 505 00:23:51,230 --> 00:23:58,370 COMPARABLE. NO MAJOR INHIBITORY 506 00:23:58,370 --> 00:23:59,738 EFFECT SO JUST SPENDING TIME 507 00:23:59,738 --> 00:24:00,806 WITH TARGET. THIS IS A 508 00:24:00,806 --> 00:24:02,074 QUANTIFICATION I WANT TO SHOW 509 00:24:02,074 --> 00:24:04,610 YOU. THIS IS CONTROL MICE, 70% 510 00:24:04,610 --> 00:24:07,746 TIME SOCIAL TARGET AND MICE THEY 511 00:24:07,746 --> 00:24:11,817 -- EVEN WITH OR WITHOUT -- THEY 512 00:24:11,817 --> 00:24:13,519 SPEND SMALL MEDIAN AMOUNT OF 513 00:24:13,519 --> 00:24:15,287 TIME WITH SOCIAL TARGET SO 514 00:24:15,287 --> 00:24:18,324 SOCIAL DEFICIT BEHAVIOR 515 00:24:18,324 --> 00:24:20,326 PHENOTYPE. WE GIVE ANOTHER 516 00:24:20,326 --> 00:24:22,361 IMMUNE STIMULUS. WE DECIDED TO 517 00:24:22,361 --> 00:24:26,432 USE APF BECAUSE WHEN YOU GIVE 518 00:24:26,432 --> 00:24:30,102 NO, MA'AM MULTI-IT WILL -- WE 519 00:24:30,102 --> 00:24:31,337 DECIDE TO GIVE A DIFFERENT 520 00:24:31,337 --> 00:24:36,475 STIMULUS. WHAT HAPPENED IS WE 521 00:24:36,475 --> 00:24:40,946 SAW SOCIAL ABILITY. WITH HIGHER 522 00:24:40,946 --> 00:24:43,749 LEVEL OF MOUSE DEVELOP BEHAVIOR, 523 00:24:43,749 --> 00:24:46,118 EVERYTHING COMES OUTS TO -- WE 524 00:24:46,118 --> 00:24:50,589 GIVE PEERS THAT IS NOVEL, THEIR 525 00:24:50,589 --> 00:24:54,226 OVERALL INDUCE PHENOTYPE WAS 526 00:24:54,226 --> 00:24:59,531 STILL CELL TEMPORALLY ROBUST 527 00:24:59,531 --> 00:25:02,434 RESCUE SOCIAL ABILITY PHENOTYPE. 528 00:25:02,434 --> 00:25:03,502 THE SAME BEHAVIOR PHENOTYPE AS 529 00:25:03,502 --> 00:25:09,641 WELL. SO WE ARE ABLE TO 530 00:25:09,641 --> 00:25:11,977 RECAPITULATE WHAT IS SHOWN IN 531 00:25:11,977 --> 00:25:16,281 HUMAN IN CERTAIN AUTISTIC 532 00:25:16,281 --> 00:25:18,417 INDIVIDUAL CORE SYMPTOMS CAN 533 00:25:18,417 --> 00:25:21,086 IMPROVE. NEXT QUESTION IS IS 534 00:25:21,086 --> 00:25:23,122 PEOPLE OR IS IT OTHER NON-FEVER 535 00:25:23,122 --> 00:25:26,125 RELATED IMMUNE MOLECULE? HOW DO 536 00:25:26,125 --> 00:25:28,127 WE INDUCE FEVER? WE INDUCE 537 00:25:28,127 --> 00:25:31,663 INFLAMMATION. NEURAL BALANCE 538 00:25:31,663 --> 00:25:35,868 WITH ALL NEW TECHNIQUE AND THEN 539 00:25:35,868 --> 00:25:38,437 BASICALLY BY INHIBITING NEURONAL 540 00:25:38,437 --> 00:25:40,973 ACTIVITY IN CERTAIN BRAIN AREA, 541 00:25:40,973 --> 00:25:44,510 HYPOTHALAMIC REGION. YOU DO 542 00:25:44,510 --> 00:25:46,545 THAT, INFLUENCE PARTICULAR BRAIN 543 00:25:46,545 --> 00:25:49,314 LOCUST YOU CAN INCREASE, IN THIS 544 00:25:49,314 --> 00:25:52,718 CASE NO INFLAMMATION. SO WHAT WE 545 00:25:52,718 --> 00:25:54,520 ASK IS INCREASE THE TEMPERATURE 546 00:25:54,520 --> 00:25:56,355 AND THAT CAN HAPPEN, THE MOUSE 547 00:25:56,355 --> 00:26:00,225 STILL SHOW REDUCE ASSOCIATED 548 00:26:00,225 --> 00:26:02,895 PHENOTYPE SUGGESTING THAT IN 549 00:26:02,895 --> 00:26:06,031 THIS CASE INCREASING TEMPERATURE 550 00:26:06,031 --> 00:26:09,401 IS NOT SUFFICIENT OR MITIGATING 551 00:26:09,401 --> 00:26:13,872 BEHAVIOR ABNORMALITY. SO FACING 552 00:26:13,872 --> 00:26:19,311 A FEVER, FOR VARIOUS REASON WE 553 00:26:19,311 --> 00:26:21,547 CYTOKINES MEASURE CYTOKINE WITH 554 00:26:21,547 --> 00:26:23,816 OR WITHOUT INJECTION AND NOTICE 555 00:26:23,816 --> 00:26:26,952 THAT FIRST COMPARE TO CONTROL 556 00:26:26,952 --> 00:26:32,224 GROUP, (INAUDIBLE) APS INDUCE 557 00:26:32,224 --> 00:26:34,493 MORE CYTOKINE PRODUCTION IN MIL 558 00:26:34,493 --> 00:26:37,896 STRENGTH SO WE PUBLISHED A PAPER 559 00:26:37,896 --> 00:26:42,768 IN IMMUNITY LAST YEAR SO MICE 560 00:26:42,768 --> 00:26:43,502 IMMUNOSYSTEM REMEMBER WHAT 561 00:26:43,502 --> 00:26:44,636 HAPPENED DURING PREGNANCY AND 562 00:26:44,636 --> 00:26:47,072 IMMUNE SYSTEM WHEN THEY GET 563 00:26:47,072 --> 00:26:50,309 (INAUDIBLE) THEY BECOME MORE 564 00:26:50,309 --> 00:27:00,752 HYPERACTIVATED. SO PROMOTE 565 00:27:03,922 --> 00:27:04,756 BEHAVIOR BY ACTING ON THE STRESS 566 00:27:04,756 --> 00:27:06,391 PATHWAY. IN THIS CASE WE THOUGHT 567 00:27:06,391 --> 00:27:11,530 MAYBE IL 17 HERE, SOME OTHER 568 00:27:11,530 --> 00:27:14,032 REASON PLAY AN IMPORTANT ROLE 569 00:27:14,032 --> 00:27:17,202 MITIGATING THE SOCIAL ABILITY 570 00:27:17,202 --> 00:27:20,105 PHENOTYPE SO QUESTION WILL IL 17 571 00:27:20,105 --> 00:27:21,673 LEAD TO BEHAVIOR RESCUE. FIRST 572 00:27:21,673 --> 00:27:24,443 WE INTRODUCE WE INHIBITED IL 17 573 00:27:24,443 --> 00:27:26,712 ACTIVITY IN THE BRAIN BY 574 00:27:26,712 --> 00:27:28,514 INTRODUCING BELONGING ANTIBODY 575 00:27:28,514 --> 00:27:31,350 TO CNS ALL PUBLISHED SO LET ME 576 00:27:31,350 --> 00:27:33,085 MOVE A LITTLE QUICKLY BECAUSE I 577 00:27:33,085 --> 00:27:37,456 WANT TO SHARE WITH YOU PUBLISHED 578 00:27:37,456 --> 00:27:38,156 LITERATURE. SO IN THIS CASE 579 00:27:38,156 --> 00:27:43,228 BLOCKING IL 17 ACTIVITY IN THE 580 00:27:43,228 --> 00:27:47,366 BRAIN THEN WE NEURONAL DETECT 581 00:27:47,366 --> 00:27:49,268 INCREASE SOCIAL ABILITY, IF WE 582 00:27:49,268 --> 00:27:51,003 BLOCK INTERFERON GAMMA AND 583 00:27:51,003 --> 00:27:55,140 (INAUDIBLE) SO IL 17 ACTIVITY IN 584 00:27:55,140 --> 00:27:57,943 THE BRAIN MAY PLAY A ROLE IN 585 00:27:57,943 --> 00:28:01,179 MITIGATING SOCIAL DEFICIT. 586 00:28:01,179 --> 00:28:04,616 PREVIOUSLY (INAUDIBLE) IDENTIFY 587 00:28:04,616 --> 00:28:08,287 IMPORTANT BRAIN AREA THAT WHERE 588 00:28:08,287 --> 00:28:09,588 INCREASE NEURONAL ACTIVITY LED 589 00:28:09,588 --> 00:28:13,759 TO BEHAVIOR ABNORMALITY AND THEN 590 00:28:13,759 --> 00:28:15,661 SUPPRESS NEURAL ACTIVITY SHE WAS 591 00:28:15,661 --> 00:28:18,297 ABLE TO TEMPORALLY RESCUE 592 00:28:18,297 --> 00:28:19,264 BEHAVIOR ABNORMALITY. WE THOUGHT 593 00:28:19,264 --> 00:28:22,401 MAYBE THIS INFLAMMATION CAN ALSO 594 00:28:22,401 --> 00:28:24,536 INFLUENCE THIS NEURONAL 595 00:28:24,536 --> 00:28:26,672 ACTIVITY, AUTOTISSIC MOUSE FOR 596 00:28:26,672 --> 00:28:28,574 VARIOUS AUTISM MODEL HAVE 597 00:28:28,574 --> 00:28:29,608 INCREASE BRAIN ACTIVITY NEURAL 598 00:28:29,608 --> 00:28:30,542 ACTIVITY IN THIS PARTICULAR 599 00:28:30,542 --> 00:28:33,111 BRAIN AREA. AND THEN WE THOUGHT 600 00:28:33,111 --> 00:28:35,781 PERIPHERAL INFLAMMATION, 601 00:28:35,781 --> 00:28:36,915 FOLLOWING THIS INJECTION NOT 602 00:28:36,915 --> 00:28:39,685 ONLY RESCUE BUT BEHAVIOR 603 00:28:39,685 --> 00:28:43,622 ABNORMALITY BUT MAY INFLUENCE 604 00:28:43,622 --> 00:28:44,790 INCREASING NEURAL ACTIVITY, THAT 605 00:28:44,790 --> 00:28:47,926 IS WHAT WE SEE AND HYPOTHESIZE 606 00:28:47,926 --> 00:28:52,931 SO SUPPORT THAT BASED ON SHOWING 607 00:28:52,931 --> 00:28:56,101 PERIPHERY REDUCE THIS 608 00:28:56,101 --> 00:28:57,202 (INAUDIBLE) SURROGATE MICE 609 00:28:57,202 --> 00:28:59,338 NEURONAL ACTIVITY AND THIS IS A 610 00:28:59,338 --> 00:29:00,539 BRAIN SPECIFIC BECAUSE WHEN YOU 611 00:29:00,539 --> 00:29:02,241 GET OTHER BRAIN REGION THERE IS 612 00:29:02,241 --> 00:29:03,809 NO CHANGE EVEN WITH INCREASE 613 00:29:03,809 --> 00:29:05,577 NEURONAL ACTIVITY. SO 614 00:29:05,577 --> 00:29:07,546 INTERESTING TO SEE KEY BRAIN 615 00:29:07,546 --> 00:29:10,015 AREA MEDIATED THAT IS IMPORTANT 616 00:29:10,015 --> 00:29:12,718 FOR BEHAVIOR ABNORMALITY, 617 00:29:12,718 --> 00:29:16,788 PERIPHERAL INFLAMMATION IS 618 00:29:16,788 --> 00:29:17,990 INTRODUCED TO ESTABLISH BACK TO 619 00:29:17,990 --> 00:29:20,959 BASELINE. THEN WE GOT THE SAME 620 00:29:20,959 --> 00:29:23,729 WHEN WE DID THE (INAUDIBLE) IN 621 00:29:23,729 --> 00:29:29,067 THIS CASE AS WELL INDUCE THE 622 00:29:29,067 --> 00:29:32,170 DIGOXIN NEURAL ACTIVITY CAN BE 623 00:29:32,170 --> 00:29:35,107 PREVENTED IF WE BLOCK ANTIBODY 624 00:29:35,107 --> 00:29:37,909 SUGGESTING THAT THIS CHANGE IN 625 00:29:37,909 --> 00:29:41,980 NEURAL ACTIVITY REQUIRES IL 17. 626 00:29:41,980 --> 00:29:45,283 IN ORDER TO UNDERSTAND WHY 627 00:29:45,283 --> 00:29:47,452 (INAUDIBLE) MORE TRAJECTORY WITH 628 00:29:47,452 --> 00:29:50,889 IL 17 CAN MEDIATE THE BEHAVIOR 629 00:29:50,889 --> 00:29:53,158 RESCUE, WE FIRST LOOK AT 630 00:29:53,158 --> 00:29:55,060 EXPRESSION OF IL 17 RECEPTOR, 631 00:29:55,060 --> 00:29:59,064 THIS IS IL 17A SUB UNIT USING 632 00:29:59,064 --> 00:30:02,300 RNA SCOPE. THIS IS RNA. THEN WE 633 00:30:02,300 --> 00:30:05,237 SAW THERE THERE IS EXPRESSION OF 634 00:30:05,237 --> 00:30:06,271 RNA INTO (INAUDIBLE) OF THE 635 00:30:06,271 --> 00:30:10,342 CORTEX. WHEN WE MOVE THAT IL 17 636 00:30:10,342 --> 00:30:13,211 RECEPTOR EXPRESSION USING 637 00:30:13,211 --> 00:30:16,448 (INAUDIBLE) ONE THING TO MENTION 638 00:30:16,448 --> 00:30:19,885 FOR IMMUNO-- PEOPLE WITH 639 00:30:19,885 --> 00:30:20,719 IMMUNOBACKGROUND, IN THE SYSTEM 640 00:30:20,719 --> 00:30:26,591 BRAIN IS STEADY, SO YOU CAN 641 00:30:26,591 --> 00:30:28,427 DELIVER THE CRE PROTEIN IN 642 00:30:28,427 --> 00:30:31,463 LOCALIZED BRAIN AREA, IN DOING 643 00:30:31,463 --> 00:30:34,199 SO YOU CAN INFECT THAT PERSON 644 00:30:34,199 --> 00:30:35,934 NOT THE NEIGHBORING REGION. ONLY 645 00:30:35,934 --> 00:30:37,502 THAT PART. SO THAT'S WHAT WE 646 00:30:37,502 --> 00:30:43,008 DID. THIS BRAIN AREA WE GET RID 647 00:30:43,008 --> 00:30:46,478 OF REACCEPT EXPRESSION AND THAT 648 00:30:46,478 --> 00:30:50,816 BRINGS BACK RESCUE. SO YOU KNEE 649 00:30:50,816 --> 00:30:53,185 IL 17 RECEPTOR A SUB UNIT 650 00:30:53,185 --> 00:30:54,653 CORTICAL BRAIN AREA. AT THAT 651 00:30:54,653 --> 00:30:57,522 TIME WE ALSO DID A EXPERIMENT IN 652 00:30:57,522 --> 00:31:01,359 THIS CASE WE INCLUDE PROTEIN 653 00:31:01,359 --> 00:31:03,061 DIRECTLY INTO THIS -- ON TOP OF 654 00:31:03,061 --> 00:31:07,466 THIS CRITICAL AREA BY DELIVERING 655 00:31:07,466 --> 00:31:09,468 WHOLE IN THE CANNELLA AND IL 17 656 00:31:09,468 --> 00:31:12,971 INTRODUCTION OF IL 17 RAY LOAN 657 00:31:12,971 --> 00:31:15,006 IS SUFFICIENT FOR SOCIAL 658 00:31:15,006 --> 00:31:16,908 BEHAVIOR SUGGESTING IL 17 659 00:31:16,908 --> 00:31:19,511 RECEPTOR IS NECESSARY IL 17 660 00:31:19,511 --> 00:31:21,213 PROTEIN IS SUFFICIENT TO INDUCE 661 00:31:21,213 --> 00:31:24,116 BEHAVIOR ABNORMALITY. THEN LATER 662 00:31:24,116 --> 00:31:30,122 WE ALSO ACHIEVE THE SAME GOAL, 663 00:31:30,122 --> 00:31:31,289 SOCIAL ABILITY, THIS IS GENETIC 664 00:31:31,289 --> 00:31:35,861 MOUSE MODEL OF AUTISM, THIS IS 665 00:31:35,861 --> 00:31:38,029 ONE OF THE MUTATION THAT ARE 666 00:31:38,029 --> 00:31:40,332 FOUND FOR HUMAN AUTISTIC 667 00:31:40,332 --> 00:31:41,633 PATIEPATIENT. IN THIS CASE THOUH 668 00:31:41,633 --> 00:31:43,301 THEY HAVE THE SAME GENETIC 669 00:31:43,301 --> 00:31:46,705 MUTATION WHEN WE INCREASE IL 17 670 00:31:46,705 --> 00:31:52,244 IN PERIPHERY IT IS SUFFICIENT TO 671 00:31:52,244 --> 00:31:55,313 PROMOTE PHENOTYPE BASICALLY MICE 672 00:31:55,313 --> 00:31:58,650 SPEND MUCH TIME EACH OTHER BUT 673 00:31:58,650 --> 00:32:00,352 IN THIS CASE FOUR HOURS AFTER WE 674 00:32:00,352 --> 00:32:02,320 INCREASE IL 17 LEVEL IN 675 00:32:02,320 --> 00:32:03,488 PERIPHERY, THE MOUSE SPEND MORE 676 00:32:03,488 --> 00:32:06,925 TIME WITH EACH OTHER AND THIS 677 00:32:06,925 --> 00:32:08,593 RESCUE PHENOTYPE LAST AROUND A 678 00:32:08,593 --> 00:32:11,463 FEW DAYS. THIS APPROACH IS NOT 679 00:32:11,463 --> 00:32:14,599 RESTRICTED TO MIA. BUT WHEN -- 680 00:32:14,599 --> 00:32:16,668 OR SHANK 3 BUT WHEN WE BRING IN 681 00:32:16,668 --> 00:32:17,736 MULTIPLE OTHER PROTEIN MOUSE 682 00:32:17,736 --> 00:32:20,772 MODEL FOR AUTISM, WE ARE ABLE TO 683 00:32:20,772 --> 00:32:22,908 (INAUDIBLE) GENETIC MUTATION AS 684 00:32:22,908 --> 00:32:26,044 WELL AS WE INCREASE IL 17 IN 685 00:32:26,044 --> 00:32:27,879 PERIPHERY, BEHAVIOR SYMPTOM IS 686 00:32:27,879 --> 00:32:28,914 SIGNIFICANT WAS SIGNIFICANTLY 687 00:32:28,914 --> 00:32:34,152 IMPROVED. SO SO FAR I TOLD YOU 688 00:32:34,152 --> 00:32:37,088 THAT IL 17 WHETHER THIS LAB 689 00:32:37,088 --> 00:32:38,890 INCREASE MANY THE BRAIN OR IN 690 00:32:38,890 --> 00:32:41,526 THE PERIPHERY, THEN YOU HAVE 691 00:32:41,526 --> 00:32:43,695 THIS MITIGATION OF BEHAVIOR 692 00:32:43,695 --> 00:32:46,998 PHENOTYPE WHICH IS INCLUDE 693 00:32:46,998 --> 00:32:49,267 SOCIAL ABILITY. SO THE QUESTION 694 00:32:49,267 --> 00:32:52,470 IS, WHY IL 17? WHAT IS SPECIFIC 695 00:32:52,470 --> 00:32:57,409 ABOUT IL 17? I GAVE A LOT OF 696 00:32:57,409 --> 00:32:59,144 THOUGHT ABOUT THIS FROM THE NEXT 697 00:32:59,144 --> 00:33:01,813 FEW SLIDES I WANT TO SHOW YOU 698 00:33:01,813 --> 00:33:06,251 ANOTHER DATA FROM MY OWN 699 00:33:06,251 --> 00:33:09,354 PERSONAL THOUGHTS. SO I WANT 700 00:33:09,354 --> 00:33:10,388 HEAR YOUR (INAUDIBLE). SO WHEN I 701 00:33:10,388 --> 00:33:13,992 FIRST THINK ABOUT IL 17 THIS IS 702 00:33:13,992 --> 00:33:17,229 INTERLEUKIN-17. i, I BEGIN TO 703 00:33:17,229 --> 00:33:20,398 WONDER OF COURSE WHENEVER I WANT 704 00:33:20,398 --> 00:33:23,668 TO SEEK ANSWER THE FIRST THING I 705 00:33:23,668 --> 00:33:29,541 DO IS RELY ON GOOGLE SO I WONDER 706 00:33:29,541 --> 00:33:31,877 WHAT INTERLEUKIN IS. I CHECK 707 00:33:31,877 --> 00:33:33,345 THIS DEFINITION AND IT SAYS A 708 00:33:33,345 --> 00:33:35,480 GROUP OF CYTOKINES EXPRESSED AND 709 00:33:35,480 --> 00:33:37,148 SECRETED BY WHITE BLOOD CELLS. 710 00:33:37,148 --> 00:33:39,117 AND THEN THE QUESTION IS, OKAY 711 00:33:39,117 --> 00:33:45,223 WHAT ARE THE CYTOKINES? I CHECK 712 00:33:45,223 --> 00:33:47,225 AGAIN THE GLOSSARY AND CYTOKINE 713 00:33:47,225 --> 00:33:48,827 IS ANY FORM OF SUBSTANCES SUCH 714 00:33:48,827 --> 00:33:51,997 AS INTERLEUKIN AND GROWTH FACTOR 715 00:33:51,997 --> 00:33:53,031 SECRETED BY CERTAIN CELLS OF THE 716 00:33:53,031 --> 00:33:56,668 IMMUNE SYSTE SYSTEM. SO INTERLES 717 00:33:56,668 --> 00:33:59,537 CYTOKINE AND CYTOKINE IS 718 00:33:59,537 --> 00:34:02,107 INTERLEUKIN. SO I WONDER 719 00:34:02,107 --> 00:34:03,441 CYTOKINE KIND OF UNDERSTANDING 720 00:34:03,441 --> 00:34:04,809 WHERE IT CAME FROM BUT WHAT 721 00:34:04,809 --> 00:34:10,548 ABOUT INTERLEUKIN? COULD BE 722 00:34:10,548 --> 00:34:12,183 CULTURAL BARRIER, SO PLEASE 723 00:34:12,183 --> 00:34:14,319 EXCUSE ME. I FOUND ON GOOGLE AN 724 00:34:14,319 --> 00:34:19,224 ARGUE SAYING THAT WILL IS A 725 00:34:19,224 --> 00:34:21,426 SWITCH AROUND, SOME OF YOU MAY 726 00:34:21,426 --> 00:34:25,530 HAVE BEEN THERE, I NEVER HEARD 727 00:34:25,530 --> 00:34:28,433 THE TERM. EXCUSE MY POOR 728 00:34:28,433 --> 00:34:30,568 PRONUNCIATION. THE CITY, AND I 729 00:34:30,568 --> 00:34:33,605 GUESS THIS IS LIKE A LAKE. YOU 730 00:34:33,605 --> 00:34:35,106 SEE A CITY BETWEEN TWO LAKES. 731 00:34:35,106 --> 00:34:37,509 THAT IS WHY IT IS CALLED THE 732 00:34:37,509 --> 00:34:40,512 INTERLAKEN. APPARENTLY THE 733 00:34:40,512 --> 00:34:42,113 INTERLEUKIN FAMILY IS NAMED 734 00:34:42,113 --> 00:34:46,084 AFTER LOCATION ENCOMPASSING 735 00:34:46,084 --> 00:34:48,219 (INAUDIBLE) 1973. HOW WE START 736 00:34:48,219 --> 00:34:50,889 TO CALL IMMUNE SECRETED IN SIGHT 737 00:34:50,889 --> 00:34:53,091 COIN INTERLEUKIN ACCORDING TO 738 00:34:53,091 --> 00:34:57,128 THIS. SO AGAIN, I'M OPEN TO 739 00:34:57,128 --> 00:35:00,198 CORRECTION ON PRONUNCIATION. 740 00:35:00,198 --> 00:35:06,371 YESTERDAY, OUR LAB -- MY THOUGHT 741 00:35:06,371 --> 00:35:08,540 PROCESS, WHENEVER I THINK ABOUT 742 00:35:08,540 --> 00:35:09,407 INTERLEUKIN YOU THINK 743 00:35:09,407 --> 00:35:11,009 INTERLEUKIN-17 SO IMMUNE RELATED 744 00:35:11,009 --> 00:35:13,611 RIGHT? SO I NEXT THING YOU KNOW 745 00:35:13,611 --> 00:35:21,653 I WENT TO TEST, THE STRUCTURE, 746 00:35:21,653 --> 00:35:28,627 FAMOUS CYTOKINE, STRUCTURE THEN 747 00:35:28,627 --> 00:35:30,962 LIKE A PIONEER HERE SITTING 748 00:35:30,962 --> 00:35:35,867 THROUGH BUT THESE CELL SIGH COIN 749 00:35:35,867 --> 00:35:38,670 RECEPTOR, WITH THE RECEPTOR 750 00:35:38,670 --> 00:35:40,872 CASCADE THROUGH LEAD TO 751 00:35:40,872 --> 00:35:42,674 ACTIVATION OF JAK STAT PATHWAY. 752 00:35:42,674 --> 00:35:49,314 SO THIS IS A REALLY -- THAT'S 753 00:35:49,314 --> 00:35:54,886 KIND OF CYTOKINE. RIGHT? SO THEN 754 00:35:54,886 --> 00:35:56,388 (INAUDIBLE) STRUCTURE PROCESS 755 00:35:56,388 --> 00:35:59,157 DIMER SOME MONOMER, SOME 756 00:35:59,157 --> 00:36:00,992 CYTOKINE DIMER BUT IF YOU LOOK 757 00:36:00,992 --> 00:36:07,265 AT IL 17 THIS IS JUST IL 17. 758 00:36:07,265 --> 00:36:09,968 DIMER, STRUCTURE AND THE 759 00:36:09,968 --> 00:36:12,237 STRUCTURE I CHECK THIS EARLIER 760 00:36:12,237 --> 00:36:14,672 WORK. BY THE WAY THIS DOWN 761 00:36:14,672 --> 00:36:18,810 SIGNALING NF KAPPA B. THEN WHEN 762 00:36:18,810 --> 00:36:23,848 I LOOK AT THE OLD LITERATURE, 763 00:36:23,848 --> 00:36:25,784 CHILDREN AND OTHER GROUP SHOW 764 00:36:25,784 --> 00:36:27,352 THE STRUCTURE IS OFTEN FOUND IN 765 00:36:27,352 --> 00:36:32,190 PROTEIN FAMILY CALLED NEURAL 766 00:36:32,190 --> 00:36:36,494 GROWTH FACTOR KNEW TROPHIN. I 767 00:36:36,494 --> 00:36:37,529 DON'T HAVE BACKGROUND IN 768 00:36:37,529 --> 00:36:38,696 STRUCTURAL BIOLOGY BUT USE FROM 769 00:36:38,696 --> 00:36:41,166 OTHER CYTOKINE AND DOWNSTREAM 770 00:36:41,166 --> 00:36:43,835 SIGNALING FROM OTHER CYTOKINES. 771 00:36:43,835 --> 00:36:46,838 SO THIS IS OUR PAPER. THAT 772 00:36:46,838 --> 00:36:49,474 ACCORDING TO IL 17 SOCIAL 773 00:36:49,474 --> 00:36:52,043 ABILITY IN MOUSE MODEL FOR 774 00:36:52,043 --> 00:36:54,279 AUTISM. THEN SO LIKE AROUND THE 775 00:36:54,279 --> 00:36:57,482 SAME -- LIKE A YEAR, TWO YEAR 776 00:36:57,482 --> 00:36:59,484 LATER, THE GROUP AT CORNELL -- 777 00:36:59,484 --> 00:37:02,020 WEILL CORNELL UNIVERSITY, HE 778 00:37:02,020 --> 00:37:06,324 FOUND IL 17 INCREASE SOCIAL 779 00:37:06,324 --> 00:37:10,962 ABILITY IN WILD TYPE MICE. SO 780 00:37:10,962 --> 00:37:13,565 THIS CONFIRMED EARLIER WORK. BUT 781 00:37:13,565 --> 00:37:16,067 THERE IS ALSO A GROUP THAT EVEN 782 00:37:16,067 --> 00:37:19,504 OLDER THAN US, SO IN 2017, GROUP 783 00:37:19,504 --> 00:37:23,475 IN UK, THEY STUDY C ELEGANS. 784 00:37:23,475 --> 00:37:26,111 THEY DID FOUR GENETIC SCREEN TO 785 00:37:26,111 --> 00:37:30,448 IDENTIFY MOLECULE THAT INHIBIT 786 00:37:30,448 --> 00:37:33,685 -- DUE TO NATURE OF THIS THE 787 00:37:33,685 --> 00:37:36,354 LEVEL OF OXIDANT AVAILABLE -- 788 00:37:36,354 --> 00:37:40,759 PHOTO AVAILABILITY C ELEGANS 789 00:37:40,759 --> 00:37:42,861 SOMETIMES KIND OF GROUPED 790 00:37:42,861 --> 00:37:43,761 TOGETHER, SOMETIMES INDIVIDUAL 791 00:37:43,761 --> 00:37:47,265 MOVE AROUND. RIGHT? SO THEY DID 792 00:37:47,265 --> 00:37:48,766 UNBIASED FOUR GENETIC SCREEN AND 793 00:37:48,766 --> 00:37:51,369 THEY WERE ABLE TO IDENTIFY IL 17 794 00:37:51,369 --> 00:37:55,640 AND IL 17 CENTER OF A KEY 795 00:37:55,640 --> 00:37:58,343 MOLECULE THAT INCREASE 796 00:37:58,343 --> 00:38:00,178 (INAUDIBLE) IN C ELEGANS. THEY 797 00:38:00,178 --> 00:38:04,582 SHOW IL 17 REACC RECEPTOR EXPREG 798 00:38:04,582 --> 00:38:06,351 IN NEURONS THAT PROMOTE 799 00:38:06,351 --> 00:38:07,852 AGGREGATION BEHAVIOR. THEY SHOW 800 00:38:07,852 --> 00:38:10,655 THAT IL 17 LIGAND CAN PROMOTE 801 00:38:10,655 --> 00:38:15,059 PHENOTYPE AS WELL. SO VERY 802 00:38:15,059 --> 00:38:16,294 EXCITING, OTHER GROUP 803 00:38:16,294 --> 00:38:18,329 (INAUDIBLE) MORE REASON TO ME 804 00:38:18,329 --> 00:38:20,899 WAS THAT IF YOU THINK ABOUT IT C 805 00:38:20,899 --> 00:38:23,001 ELEGANS THEY DON'T HAVE 806 00:38:23,001 --> 00:38:26,037 (INAUDIBLE). SO WHEN WE THINK OF 807 00:38:26,037 --> 00:38:28,940 IL 17 INTERLEUKIN 17, IT IS THE 808 00:38:28,940 --> 00:38:31,976 CYTOKINE THAT PRODUCED BY 809 00:38:31,976 --> 00:38:36,848 T-CELL, T 77 TH 3 IL 17. THOSE 810 00:38:36,848 --> 00:38:37,882 CELLS DON'T (INAUDIBLE) C 811 00:38:37,882 --> 00:38:40,385 ELEGANS BUT EVEN SO C ELEGANS 812 00:38:40,385 --> 00:38:43,621 NOT ONLY HAVE IL 17 BUT USING 813 00:38:43,621 --> 00:38:46,991 NEURAL MODULATOR. AND IL 17 IS 814 00:38:46,991 --> 00:38:49,160 ONE THOSE AGING CYTOKINE MUCH 815 00:38:49,160 --> 00:38:51,596 EARLIER IN DEVELOPMENT THAN 816 00:38:51,596 --> 00:38:55,266 INTERFERON GAMMA. SO THIS DATA 817 00:38:55,266 --> 00:38:57,869 TO MANY E SUGGESTS THAT IL 17 818 00:38:57,869 --> 00:39:01,339 COULD HAVE EVOLVED AS A NEURAL 819 00:39:01,339 --> 00:39:03,541 MODULATOR THAT REGULATORS 820 00:39:03,541 --> 00:39:06,077 AGGREGATION BEHAVIOR SOCIAL 821 00:39:06,077 --> 00:39:08,379 BEHAVIOR PHENOTYPE, (INAUDIBLE) 822 00:39:08,379 --> 00:39:10,648 FOR WHATEVER REASON IMMUNE CELLS 823 00:39:10,648 --> 00:39:14,319 FOR OTHER PURPOSES SO JUST MY 824 00:39:14,319 --> 00:39:19,891 IDEA. SO THIS IS GOING BACK TO 825 00:39:19,891 --> 00:39:23,161 SOME DATA, RIGHT? SO WE THEN 826 00:39:23,161 --> 00:39:27,332 BEGAN WONDERING HOW IL 17 827 00:39:27,332 --> 00:39:32,470 ENHANCE SOCIAL ABILITY? IN ORDER 828 00:39:32,470 --> 00:39:34,172 (INAUDIBLE) ON THIS INVASIVE 829 00:39:34,172 --> 00:39:38,309 TECHNIQUE, WHERE TO TREAT THE 830 00:39:38,309 --> 00:39:40,678 WHOLE BRAIN WE HAVE TO INTRODUCE 831 00:39:40,678 --> 00:39:42,213 (INAUDIBLE) TO THE BRAIN, SO 832 00:39:42,213 --> 00:39:44,716 MANY INVASIVE -- SO IT IS NOT 833 00:39:44,716 --> 00:39:48,519 EASY TO DO THAT, VERY ROUTINE SO 834 00:39:48,519 --> 00:39:49,754 WE WANTS TO TEST AND UNDERSTAND 835 00:39:49,754 --> 00:39:52,190 THIS ROLE MECHANISM WHICH 836 00:39:52,190 --> 00:39:53,024 (INAUDIBLE) SOCIAL ABILITY, WE 837 00:39:53,024 --> 00:39:55,159 NEED TO COME UP WITH DIFFERENT 838 00:39:55,159 --> 00:39:58,363 METHOD TO ACHIEVE THE SAME GOAL, 839 00:39:58,363 --> 00:40:00,398 INCREASE (INAUDIBLE) IN THE 840 00:40:00,398 --> 00:40:07,739 BRAIN BASICALLY. SO MY 841 00:40:07,739 --> 00:40:09,140 (INAUDIBLE) CAME UP WITH THIS 842 00:40:09,140 --> 00:40:13,511 IDEA. WHAT IF WE JUST 843 00:40:13,511 --> 00:40:17,615 (INAUDIBLE) ITALY? THERE'S 844 00:40:17,615 --> 00:40:19,550 (INDISCERNIBLE) TO THE BRAIN, 845 00:40:19,550 --> 00:40:21,753 MANY SMALL MOLECULE AND ANTIBODY 846 00:40:21,753 --> 00:40:26,457 PRETTY SURE THOSE ARE 847 00:40:26,457 --> 00:40:29,994 (INAUDIBLE) GET TO CNS. 848 00:40:29,994 --> 00:40:31,229 INITIALLY SHE TOLD ME THAT, I 849 00:40:31,229 --> 00:40:33,164 SAID NO, DON'T DO THAT, IT IS 850 00:40:33,164 --> 00:40:36,501 NOT GOING TO WORK. BUT LIKE MANY 851 00:40:36,501 --> 00:40:37,635 OTHER GOOD POST DOC SHE DIDN'T 852 00:40:37,635 --> 00:40:42,206 LISTEN TO ME. INTRODUCE THE IL 853 00:40:42,206 --> 00:40:45,944 17 SHE SHOWED ME THE BIAS IN IL 854 00:40:45,944 --> 00:40:51,382 17 SAID COME ON SHE WASN'T 855 00:40:51,382 --> 00:40:52,550 DISCOURAGING I (INAUDIBLE) BACK 856 00:40:52,550 --> 00:40:55,520 ON MICE AND IL 17 AND EVEN IN 857 00:40:55,520 --> 00:40:58,690 THE CASE OF (INDISCERNIBLE) IN A 858 00:40:58,690 --> 00:41:01,759 CORE TEST THERE IS INCREASE OF 859 00:41:01,759 --> 00:41:03,127 (INAUDIBLE) IN THE CORTICAL 860 00:41:03,127 --> 00:41:09,834 ASSAY. AND THEN WHAT TYPE OF IN 861 00:41:09,834 --> 00:41:12,537 VITRO, THAT IS JUAN WAY TO MAKE 862 00:41:12,537 --> 00:41:15,173 SOCIAL ABILITY, ANOTHER WAY IS 863 00:41:15,173 --> 00:41:17,575 DOING THE SOCIAL INTERACTION. 864 00:41:17,575 --> 00:41:20,945 PUTTING TUMORS -- MEASURING TIME 865 00:41:20,945 --> 00:41:22,980 SPENT WITH EACH OTHER QUANTIFY 866 00:41:22,980 --> 00:41:25,650 SOCIAL BEHAVIOR PHENOTYPE. 867 00:41:25,650 --> 00:41:27,385 CONTROL MICE GOOD ITERATION, MY 868 00:41:27,385 --> 00:41:31,289 MICE NOT SO GOOD INTERACTION. 869 00:41:31,289 --> 00:41:35,560 THEN WHEN (INDISCERNIBLE) GIVE 870 00:41:35,560 --> 00:41:37,562 INCREASE INTRANASALLY SHE WAS 871 00:41:37,562 --> 00:41:43,234 ABLE TO DETECT INCREASE SOCIAL 872 00:41:43,234 --> 00:41:45,670 -- THIS INCREASE FOUR TO EIGHT 873 00:41:45,670 --> 00:41:48,673 HOURS AND THEN THEY WENT BACK TO 874 00:41:48,673 --> 00:41:51,009 THIS BASELINE. SO NOW FINALLY WE 875 00:41:51,009 --> 00:41:54,379 HAVE A SYSTEM THAT ALLOW US TO 876 00:41:54,379 --> 00:41:56,781 INTRODUCE IL 17 OR INCREASE INTO 877 00:41:56,781 --> 00:41:58,916 THE BRAIN. WHAT DO WE DO NEXT? 878 00:41:58,916 --> 00:42:03,588 SO THEN WE DECIDE TO ASK, OKAY, 879 00:42:03,588 --> 00:42:06,924 HAVING IL 17 THERE, PEOPLE TALK 880 00:42:06,924 --> 00:42:08,793 ABOUT A AN F, MOST CASES BUT YOU 881 00:42:08,793 --> 00:42:12,697 CAN GET THE LITERATURE THEY ARE 882 00:42:12,697 --> 00:42:17,101 LIKE (INAUDIBLE) LIGAND. FIVE 883 00:42:17,101 --> 00:42:20,271 DIFFERENT IL 17 SUB UNIT. EACH 884 00:42:20,271 --> 00:42:24,409 SUB UNIT IN THE FORM MULTI-LAYER 885 00:42:24,409 --> 00:42:25,810 COMPLEX, TWO DIFFERENT SUB UNIT 886 00:42:25,810 --> 00:42:32,550 THE MOST FAMOUS IL 17 IS 17A 887 00:42:32,550 --> 00:42:33,851 COMPLEX INITIAL SIGNAL BUT THERE 888 00:42:33,851 --> 00:42:35,853 ARE MANY OTHER LIGANDS. SO WE 889 00:42:35,853 --> 00:42:39,957 DECIDE TO TEST THEM ALL. WHICH 890 00:42:39,957 --> 00:42:41,859 ASSAY ENHANCE SOCIAL ABILITY? SO 891 00:42:41,859 --> 00:42:44,062 TO MAKE LONG STORY SHORT WE CAN 892 00:42:44,062 --> 00:42:48,599 DETECT IL A, B, F RESCUE SOCIAL 893 00:42:48,599 --> 00:42:50,735 ABILITY DEFICIT. NOT ONLY SO, 894 00:42:50,735 --> 00:42:56,174 THIS ABEF SOCIAL ABILITY GOES TO 895 00:42:56,174 --> 00:42:58,609 MITIGATE THE BEHAVIOR PHENOTYPE 896 00:42:58,609 --> 00:43:00,912 SO TWO COURSE ALTERNATIVE CAN BE 897 00:43:00,912 --> 00:43:03,414 WITH OR -- ADDITION OF FOUR 898 00:43:03,414 --> 00:43:05,349 DIFFERENT LIGANDS OF BIAS 899 00:43:05,349 --> 00:43:11,656 (INAUDIBLE) SO I JUST TOLD YOU 900 00:43:11,656 --> 00:43:15,126 RESCUE SOCIAL ABILITY STEP ONE, 901 00:43:15,126 --> 00:43:17,562 IF YOU LOOK AT THAT, THEY ARE -- 902 00:43:17,562 --> 00:43:19,897 YOU CAN ESSENTIALLY DETECT 903 00:43:19,897 --> 00:43:21,732 DIFFERENT RECEPTOR SUB UNIT, RA 904 00:43:21,732 --> 00:43:25,470 RC AND RB. SO THEN WE NEXT ASK 905 00:43:25,470 --> 00:43:28,840 WE WANTED TO ASK WHERE ARE THESE 906 00:43:28,840 --> 00:43:31,909 RECEPTORS EXPRESSED IN THE 907 00:43:31,909 --> 00:43:34,178 BRAIN? AS SOME OF YOU MAY KNOW, 908 00:43:34,178 --> 00:43:37,849 THE CYTOKINE EXPRESSION 909 00:43:37,849 --> 00:43:38,850 (INAUDIBLE) SO THERE ARE 910 00:43:38,850 --> 00:43:40,218 ANTIBODIES ARE TERRIBLE. DON'T 911 00:43:40,218 --> 00:43:41,686 BUY THOSE ANTIBODIES. THEY 912 00:43:41,686 --> 00:43:43,087 DIDN'T WORK. WE BASICALLY TESTED 913 00:43:43,087 --> 00:43:46,958 THEM ALL. SO THEN IF YOU DO 914 00:43:46,958 --> 00:43:49,627 BASICALLY SPATIAL TRANSCRIPTOME, 915 00:43:49,627 --> 00:43:52,296 YOU GET ALL THE INFORMATION YOU 916 00:43:52,296 --> 00:43:57,101 NEED. THERE'S SO MANY TO 917 00:43:57,101 --> 00:43:58,503 INVOLVE, WE COULDN'T GET THE 918 00:43:58,503 --> 00:43:59,637 RESOLUTION WE WANTED TO ACHIEVE 919 00:43:59,637 --> 00:44:02,240 SO WE DECIDE TO THROUGH THE 920 00:44:02,240 --> 00:44:04,675 PANDEMIC WE SAID OKAY, LET'S 921 00:44:04,675 --> 00:44:07,145 MAKE MICE, JUST USE GENETICS TO 922 00:44:07,145 --> 00:44:09,080 IDENTIFY WHERE THEY THEY ARE 923 00:44:09,080 --> 00:44:13,217 LOCATED SO WE BASED GENETICS ON 924 00:44:13,217 --> 00:44:14,418 (INDISCERNIBLE) BY TRANSFERRING 925 00:44:14,418 --> 00:44:17,188 THE CRE DEPENDENTS BIOSAY TO THE 926 00:44:17,188 --> 00:44:19,657 BRAIN WE BASICALLY ARE ABLE TO 927 00:44:19,657 --> 00:44:21,726 MAP OUT AND KNOW WHERE THEY ARE 928 00:44:21,726 --> 00:44:24,595 LOCATED. SO IF YOU ASK WHERE IS 929 00:44:24,595 --> 00:44:29,167 CYTOKINE EXPRESSED, BEFORE WE DO 930 00:44:29,167 --> 00:44:30,768 THIS EXPERIMENT, THE TRUE 931 00:44:30,768 --> 00:44:31,669 GENERAL ANSWER IS I DON'T KNOW 932 00:44:31,669 --> 00:44:35,106 OR EVERYWHERE. WE START TO LOOK 933 00:44:35,106 --> 00:44:37,909 AT THIS, WELL -- THAT IS NOT THE 934 00:44:37,909 --> 00:44:41,379 CASE. EVERY SINGLE BRAIN, 935 00:44:41,379 --> 00:44:42,847 DIFFERENT EXPRESSION PATTERN. 936 00:44:42,847 --> 00:44:47,618 RA, THERE IS A HIGH EXPRESSION 937 00:44:47,618 --> 00:44:49,220 RB SO SOME THROUGHOUT THE CORTEX 938 00:44:49,220 --> 00:44:54,592 BUT RC WHICH IS LIKE RECEPTORS 939 00:44:54,592 --> 00:44:56,594 IN INCH 90%, THIS IS ALL 940 00:44:56,594 --> 00:44:59,430 NEURONS. ONLY WE JUST TESTED 941 00:44:59,430 --> 00:45:01,999 NEURONAL EXPRESSION. AND REA IS 942 00:45:01,999 --> 00:45:04,001 MORE SPARSE. SO WE THOUGHT THAT 943 00:45:04,001 --> 00:45:06,037 BASED ON THIS DATA, I TOLD YOU 944 00:45:06,037 --> 00:45:11,442 THAT RA RB RC RESCUE, TO 945 00:45:11,442 --> 00:45:13,978 SEPARATE PHENOTYPE BASED ON THIS 946 00:45:13,978 --> 00:45:15,112 LIGAND, SPACING. BASED ON THIS 947 00:45:15,112 --> 00:45:17,882 DATA WE KNOW THE CORTICAL AREA 948 00:45:17,882 --> 00:45:19,750 AROUND HERE IS IMPORTANT FOR THE 949 00:45:19,750 --> 00:45:21,752 SOCIAL RESCUE, BASED ON THIS 950 00:45:21,752 --> 00:45:24,589 DATA WE THOUGHT RA AND RD PLAY A 951 00:45:24,589 --> 00:45:27,091 ROLE BUT NOT RC. THEN WE TOOK 952 00:45:27,091 --> 00:45:30,728 GENETIC -- BEFORE THAT WE 953 00:45:30,728 --> 00:45:33,364 SEQUENCE THAT'S WHY IT IS GREEN, 954 00:45:33,364 --> 00:45:35,833 WE PUT THE DIFFERENT EXPRESSION 955 00:45:35,833 --> 00:45:37,201 NEURONS ARE DISTANT SO THEY HAVE 956 00:45:37,201 --> 00:45:41,105 A DIFFERENT PROGRAM. THEN SO 957 00:45:41,105 --> 00:45:43,774 NEXT WE ASK WHAT HAPPENED WHICH 958 00:45:43,774 --> 00:45:47,745 GENETICALLY REMOVING -- COULD RB 959 00:45:47,745 --> 00:45:52,450 RC RA PREVIOUS ISSUE THAT RA IS 960 00:45:52,450 --> 00:45:54,051 CRITICAL. SO WE HAVE TO 961 00:45:54,051 --> 00:45:56,487 (INAUDIBLE) RC USING, THIS IS 962 00:45:56,487 --> 00:46:02,026 THE MOST NEURONAL CELL WHEN YOU 963 00:46:02,026 --> 00:46:05,429 REMOVE 17A AND 17E DEPENDENT 964 00:46:05,429 --> 00:46:07,732 RESCUE WERE NOT AFFECTED. SO 965 00:46:07,732 --> 00:46:10,635 THIS DATA IS RC IS DISPENSABLE 966 00:46:10,635 --> 00:46:14,572 AND AT LEAST FOR THIS SOCIAL 967 00:46:14,572 --> 00:46:16,641 RESCUE. WHAT ABOUT RB, WHEN HE 968 00:46:16,641 --> 00:46:20,344 YOU REMOVE RB LIGAND RESCUE THIS 969 00:46:20,344 --> 00:46:23,914 PHENOTYPE. THIS DATA SUGGESTS 970 00:46:23,914 --> 00:46:27,118 THAT (INAUDIBLE) RA RB PLAY A 971 00:46:27,118 --> 00:46:32,990 CRITICAL ROLE IN RESCUE, THEN WE 972 00:46:32,990 --> 00:46:34,125 GENERATED ANOTHER MOUSE LINE, IN 973 00:46:34,125 --> 00:46:38,229 DOING SO WE ARE ABLE TO IDENTIFY 974 00:46:38,229 --> 00:46:41,432 (INAUDIBLE) RC -- RB AND RA AND 975 00:46:41,432 --> 00:46:45,102 THEN USING RA CRE MICE ANOTHER 976 00:46:45,102 --> 00:46:48,906 MOUSE WE GENERATED WE CAN INDUCE 977 00:46:48,906 --> 00:46:50,641 RB BASED ON DOUBLE POSITIVE 978 00:46:50,641 --> 00:46:54,645 CELLS, THE RB EXPRESSION WE NO 979 00:46:54,645 --> 00:46:57,348 LONGER SEE RESCUE PHENOTYPE 980 00:46:57,348 --> 00:46:58,716 SUGGESTING THAT THESE CELLS THAT 981 00:46:58,716 --> 00:47:00,418 EXPRESS -- THEY NEED TO EXPRESS 982 00:47:00,418 --> 00:47:05,723 BOTH RA AND RB. TO THIS LIGAND. 983 00:47:05,723 --> 00:47:07,825 AND PRODUCE SOCIAL RESCUE 984 00:47:07,825 --> 00:47:11,028 PHENOTYPE. SO THE QUESTION WE 985 00:47:11,028 --> 00:47:16,167 ARE ASKING SO OKAY RB AND RA ARE 986 00:47:16,167 --> 00:47:18,936 IMPORTANT. BUT HERE WE HAVE A 987 00:47:18,936 --> 00:47:22,173 PROBLEM. I ALREADY TOLD YOU 17A 988 00:47:22,173 --> 00:47:24,842 AND THEN A F E RESCUE THE 989 00:47:24,842 --> 00:47:27,044 PHENOTYPE, RIGHT? CONTAIN THE 990 00:47:27,044 --> 00:47:29,046 SOCIAL ABILITY INDUCE SOCIAL 991 00:47:29,046 --> 00:47:31,816 ABILITY ESTIMATE BUT WE FOUND RB 992 00:47:31,816 --> 00:47:34,151 IS IMPORTANT, NOT RC IMPORTANT 993 00:47:34,151 --> 00:47:35,786 BUT ALL THE DATA OUT THERE 994 00:47:35,786 --> 00:47:39,757 SUGGEST THAT YOU NEED RA AND RC 995 00:47:39,757 --> 00:47:42,493 FOR 17A. SO I TOLD YOU 17A LEADS 996 00:47:42,493 --> 00:47:45,896 TO SOCIAL RESCUE BUT THAT YOU 997 00:47:45,896 --> 00:47:47,832 NEED EXPRESSION OF RC AND 998 00:47:47,832 --> 00:47:49,834 NEURONAL CELL, YOU DON'T NEED RC 999 00:47:49,834 --> 00:47:52,636 -- HOW DOES THIS WORK? HOW DOES 1000 00:47:52,636 --> 00:47:55,172 THE RESCUE BECAUSE RC IS NOT 1001 00:47:55,172 --> 00:47:57,508 REQUIRED? SO WE HIGH BOTH SIZE 1002 00:47:57,508 --> 00:48:02,146 THAT PERHAPS -- HYPOTHESIZE 17A 1003 00:48:02,146 --> 00:48:05,783 FUNCTION BASED ON 17E, BASED ON 1004 00:48:05,783 --> 00:48:07,318 EVERYTHING I TRY TO SHARE WITH 1005 00:48:07,318 --> 00:48:10,221 YOU WE INTRODUCE 17A 1006 00:48:10,221 --> 00:48:14,692 INTRANASALLY AND FOUND THAT 17E 1007 00:48:14,692 --> 00:48:17,027 ADMINISTRATION LEAD TO 1008 00:48:17,027 --> 00:48:20,698 EXPRESSION OF 17E BY mRNA AND 1009 00:48:20,698 --> 00:48:23,200 ALSO PROTEIN AS WELL. SO 17A CAN 1010 00:48:23,200 --> 00:48:27,171 INCREASE IL 17E AND IL 17E CAN 1011 00:48:27,171 --> 00:48:31,041 FUNCTION THROUGH RA RB. SO NEXT 1012 00:48:31,041 --> 00:48:35,479 PERSON, OKAY, IF REALLY THE CASE 1013 00:48:35,479 --> 00:48:40,551 17A CAN MODULATE NEURAL 1014 00:48:40,551 --> 00:48:43,721 ACTIVITY, SO WE DID THE -- WE 1015 00:48:43,721 --> 00:48:46,056 MEASURED THE NEURAL ACTIVITY 1016 00:48:46,056 --> 00:48:49,693 FROM THE BRAIN AREA IMPORTANT 1017 00:48:49,693 --> 00:48:52,863 FOR THIS SOCIAL ABILITY 1018 00:48:52,863 --> 00:48:55,232 PHENOTYPE THEN APPLY 17A 1019 00:48:55,232 --> 00:48:57,902 COMPARED TO -- THIS IS IMMEDIATE 1020 00:48:57,902 --> 00:49:00,204 RESPONSE. WHEN WE ADD 17A OPT 1021 00:49:00,204 --> 00:49:02,873 PETRI DISHES WE MEASURE THIS 1022 00:49:02,873 --> 00:49:06,544 NEURAL ACTIVITY FROM 17RB 1023 00:49:06,544 --> 00:49:08,212 POSITIVE CELL WE CAN SEE IMAGE 1024 00:49:08,212 --> 00:49:10,147 OF THIS NEURAL ACTIVITY, FROM 1025 00:49:10,147 --> 00:49:12,249 POSITION OF 17A SUGGESTING THAT 1026 00:49:12,249 --> 00:49:14,618 17E CAN FUNCTION AS NEURAL 1027 00:49:14,618 --> 00:49:16,153 MODULATOR. IN THIS CASE. SO NEXT 1028 00:49:16,153 --> 00:49:20,057 QUESTION WE ASKED, OKAY, EVEN IF 1029 00:49:20,057 --> 00:49:22,593 THAT IS THE CASE 17A REQUIRES 1030 00:49:22,593 --> 00:49:24,628 17A WE PERFORMED AN EPISTATIC 1031 00:49:24,628 --> 00:49:29,800 EXPERIMENT. SO IN THIS CASE WE 1032 00:49:29,800 --> 00:49:33,537 GENERATED 17A AND THIS 1033 00:49:33,537 --> 00:49:35,873 BACKGROUND WHEN WE GIVE 17A OR E 1034 00:49:35,873 --> 00:49:40,678 WE ARE ABLE TO SEE SOCIAL 1035 00:49:40,678 --> 00:49:42,012 ABILITY PHENOTYPE. HOWEVER THE 1036 00:49:42,012 --> 00:49:46,484 SAME EXPERIMENT WITH 17E ON 1037 00:49:46,484 --> 00:49:48,586 MICE, 17E WHILE CAN ENHANCE 1038 00:49:48,586 --> 00:49:49,720 SOCIAL ABILITY 17 A NO LONGER 1039 00:49:49,720 --> 00:49:51,488 DOES THAT. SO THIS DATA 1040 00:49:51,488 --> 00:49:53,524 SUGGESTING THAT 17E IS 1041 00:49:53,524 --> 00:49:55,459 (INAUDIBLE) TO 17A AND I ALREADY 1042 00:49:55,459 --> 00:49:58,796 TOLD YOU 17A CAN ENHANCE 17E. 1043 00:49:58,796 --> 00:50:00,798 SO ALL THIS DATA TOGETHER IS 1044 00:50:00,798 --> 00:50:07,004 JUST A MODEL THAT 17A 1045 00:50:07,004 --> 00:50:08,606 POTENTIALLY ACT IN NON-NEURONAL 1046 00:50:08,606 --> 00:50:10,608 CELL WE DON'T KNOW NATURE OF THE 1047 00:50:10,608 --> 00:50:13,444 CELL AND LEAD TO INCREASE 17E 1048 00:50:13,444 --> 00:50:19,183 AND THIS 17E IN -- RECEPTOR A 1049 00:50:19,183 --> 00:50:21,785 AND RECEPTOR B COMPLEX AND IN 1050 00:50:21,785 --> 00:50:24,154 DOING SO BRING DOWN INCREASE 1051 00:50:24,154 --> 00:50:25,756 HYPERNEURAL ACTIVITY BACK TO 1052 00:50:25,756 --> 00:50:28,225 BASELINE, THEN BASICALLY ENHANCE 1053 00:50:28,225 --> 00:50:30,794 SOCIAL ABILITY IN THIS ANIMAL 1054 00:50:30,794 --> 00:50:33,597 MODEL. THEN WE FOUND THAT 1055 00:50:33,597 --> 00:50:37,601 (INAUDIBLE) IL 17A AND E CAN 1056 00:50:37,601 --> 00:50:38,702 ENHANCE SOCIAL ABILITY 1057 00:50:38,702 --> 00:50:40,771 PHENOTYPE, NOT ONLY SO THIS THIS 1058 00:50:40,771 --> 00:50:42,373 CAN BE APPLICABLE TO 1059 00:50:42,373 --> 00:50:44,875 DIFFERENTIATED MOUSE MODEL OF 1060 00:50:44,875 --> 00:50:46,143 AUTISM, NOT JUST -- DIFFERENT 1061 00:50:46,143 --> 00:50:48,879 MOUSE WITH AUTISM, ADDITIONAL 1062 00:50:48,879 --> 00:50:51,181 17A OR E SUFFICIENT TO ENHANCE 1063 00:50:51,181 --> 00:50:53,317 PHENOTYPE. SO I HOPE THAT I WAS 1064 00:50:53,317 --> 00:50:55,619 ABLE TO CONVINCE YOU THAT THIS 1065 00:50:55,619 --> 00:51:00,190 PATHWAY TO REGULATORY MECHANISM 1066 00:51:00,190 --> 00:51:02,826 CYTOKINE OR IN THIS LIGAND HAD 1067 00:51:02,826 --> 00:51:06,397 ABILITY TO CONTROL NEURAL 1068 00:51:06,397 --> 00:51:07,898 ACTIVITY, MAY HAVE MORE ANCIENT 1069 00:51:07,898 --> 00:51:12,303 FUNCTION. SO BASICALLY WE THINK 1070 00:51:12,303 --> 00:51:15,072 AHEAD. WE ARE THINKING ABOUT 1071 00:51:15,072 --> 00:51:16,573 IMMUNOTHERAPY FOR THE DISORDER. 1072 00:51:16,573 --> 00:51:19,777 CAN WE COME UP WITH A WAY TO 1073 00:51:19,777 --> 00:51:23,881 EDUCATE IN CELLS FROM THE GUT IN 1074 00:51:23,881 --> 00:51:26,483 VITRO, CAN WE -- IT IS NOT CLEAR 1075 00:51:26,483 --> 00:51:27,518 WHETHER (INAUDIBLE) CAN 1076 00:51:27,518 --> 00:51:28,852 INFLUENCE CELL BRAIN NEURAL 1077 00:51:28,852 --> 00:51:31,155 ACTIVITY ACTUALLY BUT CAN WE 1078 00:51:31,155 --> 00:51:32,723 UTILIZE THE (INAUDIBLE) CELL AS 1079 00:51:32,723 --> 00:51:36,794 A VEHICLE TO PRODUCE -- TO 1080 00:51:36,794 --> 00:51:38,395 IMPACT NEURAL ACTIVITY IN THE 1081 00:51:38,395 --> 00:51:41,799 BRAIN AND THEN IN DOING SO 1082 00:51:41,799 --> 00:51:45,703 VENOUS CELL CAN ACT AS A SEARCH 1083 00:51:45,703 --> 00:51:51,976 BY ENGAGING IN CYTOKINE RECEPTOR 1084 00:51:51,976 --> 00:51:55,012 ACTIVITY. SO WE THINK THIS 1085 00:51:55,012 --> 00:51:56,313 PATHWAY IS IMMUNE TOE BRAIN 1086 00:51:56,313 --> 00:52:01,852 CIRCUIT IS REALLY IMPORTANT AND 1087 00:52:01,852 --> 00:52:05,122 I HOPE I'M SURE GLORIA WILL 1088 00:52:05,122 --> 00:52:06,824 SHARE WITH YOU SOME OTHER DATA 1089 00:52:06,824 --> 00:52:11,996 FOCUSED ON DIFFERENT CYTOKINE 1090 00:52:11,996 --> 00:52:17,301 RECEPTORS, TO ATEN THE TALK. SO 1091 00:52:17,301 --> 00:52:21,905 BASICALLY SUMMARY. I HAVE 1092 00:52:21,905 --> 00:52:24,108 (INAUDIBLE) CYTOKINE MODULATED 1093 00:52:24,108 --> 00:52:26,176 BY NEURAL ACTIVITY. WE IDENTIFY 1094 00:52:26,176 --> 00:52:27,611 POTENTIAL LIGANDS THAT HAVE SUCH 1095 00:52:27,611 --> 00:52:29,647 ACTIVITY, WE MAP OUT THE BRAIN 1096 00:52:29,647 --> 00:52:32,316 AREA, THAT EXPRESS DIFFERENT 1097 00:52:32,316 --> 00:52:34,184 RECEPTOR SUB UNIT AND THEN WE 1098 00:52:34,184 --> 00:52:37,488 ARE ABLE TO SHOW GENETICALLY WE 1099 00:52:37,488 --> 00:52:38,822 CHALLENGE RECEPTOR TO PLAY A 1100 00:52:38,822 --> 00:52:40,591 ROLE IN MODULATING THE SOCIAL 1101 00:52:40,591 --> 00:52:45,429 ABILITY OF PHENOTYPE. 1102 00:52:45,429 --> 00:52:47,297 SOCIOIBILITY OF PHENOTYPE. THIS 1103 00:52:47,297 --> 00:52:49,667 WORK ESSENTIALLY IS DONE BY -- 1104 00:52:49,667 --> 00:52:51,602 THROUGH COLLABORATION BY 1105 00:52:51,602 --> 00:52:56,874 (INAUDIBLE) IN MY LAB AND -- 1106 00:52:56,874 --> 00:52:59,043 PUBLISHED THE WORK I SHOW YOU, 1107 00:52:59,043 --> 00:53:01,779 THIS IS PEOPLE I WANT TO END, MY 1108 00:53:01,779 --> 00:53:04,314 FUNDING SOURCES. THANK YOU VERY 1109 00:53:04,314 --> 00:53:06,216 MUCH FOR YOUR ATTENTION. HAPPY 1110 00:53:06,216 --> 00:53:11,388 TO TAKE ANY QUESTIONS. 1111 00:53:11,388 --> 00:53:12,389 >> THANK YOU VERY MUCH, THAT WAS 1112 00:53:12,389 --> 00:53:14,525 REALLY A LOVELY TALK. I DIDN'T 1113 00:53:14,525 --> 00:53:17,127 KNOW THAT IL 17 IS A HAPPY HOUR 1114 00:53:17,127 --> 00:53:23,667 CYTOKINE. BUT I THINK TIME FOR 1115 00:53:23,667 --> 00:53:23,934 QUESTIONS. 1116 00:53:23,934 --> 00:53:26,537 >> VERY NICE TALK. THANK YOU. I 1117 00:53:26,537 --> 00:53:28,972 WAS WONDERING MAYBE I MISSED 1118 00:53:28,972 --> 00:53:31,275 THIS POINT. WHICH SOURCE OR 1119 00:53:31,275 --> 00:53:34,378 WHICH SOURCES MIGHT BE FOR IL 1120 00:53:34,378 --> 00:53:36,713 17E? BECAUSE IF I REMEMBER 1121 00:53:36,713 --> 00:53:38,382 CORRECTLY, I'M MAINLY FOCUSING 1122 00:53:38,382 --> 00:53:43,420 ON THE SKIN AND THERE IT IS NOT 1123 00:53:43,420 --> 00:53:43,887 HEMATOPOIETIC CELLS. 1124 00:53:43,887 --> 00:53:47,124 >> I DIDN'T CARRY THAT BUT 1125 00:53:47,124 --> 00:53:49,159 NEURONAL CELL AND NON-NEURONAL 1126 00:53:49,159 --> 00:53:50,594 CELLS PRODUCE, THEY ARE 1127 00:53:50,594 --> 00:53:52,796 PRODUCING IL 17E IN THE BRAIN 1128 00:53:52,796 --> 00:53:56,667 EVEN AT STEADY STATE AND UPON 1129 00:53:56,667 --> 00:53:56,967 (INAUDIBLE) 1130 00:53:56,967 --> 00:53:59,236 >> THANK YOU. 1131 00:53:59,236 --> 00:54:01,205 >> GREAT TALK. THAT WAS REALLY 1132 00:54:01,205 --> 00:54:04,575 -- SO IN YOUR AUTISM MODELS, DO 1133 00:54:04,575 --> 00:54:07,878 WE SEE DECREASING IL 17A OR 1134 00:54:07,878 --> 00:54:10,280 EXPRESSION FOR RECEPTORS AND ANY 1135 00:54:10,280 --> 00:54:11,548 IDEA HOW IT CAN BE RELATED? 1136 00:54:11,548 --> 00:54:14,952 >> IT IS COMPLICATED OBVIOUSLY. 1137 00:54:14,952 --> 00:54:16,987 IL 17 AS MENTIONED I DIDN'T TALK 1138 00:54:16,987 --> 00:54:19,590 ABOUT THAT EARLIER WORK BUT IL 1139 00:54:19,590 --> 00:54:21,792 17 IN THE MODEL DURING PREGNANCY 1140 00:54:21,792 --> 00:54:24,995 CAN PROMOTE PHENOTYPE IN THE 1141 00:54:24,995 --> 00:54:27,331 OFFSPRING. THEN THAT IS LIKE A 1142 00:54:27,331 --> 00:54:28,966 STRESS PATHWAY WE SHOW THAT IT 1143 00:54:28,966 --> 00:54:35,539 IS ENGAGE INDUCE UPR PATHWAY, SO 1144 00:54:35,539 --> 00:54:39,176 GETTING BACK TO YOUR QUESTION, 1145 00:54:39,176 --> 00:54:42,546 YEAH, I (INAUDIBLE) THE QUESTION 1146 00:54:42,546 --> 00:54:45,082 WHETHER LIGANDS PLAY -- HAVE A 1147 00:54:45,082 --> 00:54:48,919 PHYSIOLOGICAL FUNCTION TO 1148 00:54:48,919 --> 00:54:50,387 MODULATE SOCIABILITY. I WAS ABLE 1149 00:54:50,387 --> 00:54:53,290 TO CONVINCE (INAUDIBLE) TO 1150 00:54:53,290 --> 00:54:56,260 GENERATE KNOCK ON MICE, REMOVE 1151 00:54:56,260 --> 00:55:00,097 ALL LIGAND. SO CAN WE SHOW THAT 1152 00:55:00,097 --> 00:55:04,434 A, B, E, PLAY A ROLE AND MOVE 1153 00:55:04,434 --> 00:55:07,304 ONLY ONE LIGAND SUFFICIENT TO 1154 00:55:07,304 --> 00:55:09,339 INDUCE THE PHENOTYPE, BASED ON 1155 00:55:09,339 --> 00:55:10,741 (INAUDIBLE) DATA WE MAY HAVE TO 1156 00:55:10,741 --> 00:55:14,011 SEE SOME EFFECT SO SHE IS DOING 1157 00:55:14,011 --> 00:55:15,479 MOUSE CROSS -- BUT IT IS MANY 1158 00:55:15,479 --> 00:55:16,480 THAT DIFFICULT BECAUSE A AND F 1159 00:55:16,480 --> 00:55:19,716 ARE MANY THE SAME LOCI SO IT IS 1160 00:55:19,716 --> 00:55:20,984 A TRUE KNOCK OUT. HOPEFULLY I 1161 00:55:20,984 --> 00:55:23,854 DON'T KNOW BUT I'M JUST -- MY 1162 00:55:23,854 --> 00:55:25,122 GUESS IS MAYBE SEE SOME 1163 00:55:25,122 --> 00:55:26,557 PHENOTYPE THERE. HAPPY TO TALK 1164 00:55:26,557 --> 00:55:27,257 WITH YOU MORE ABOUT THAT. 1165 00:55:27,257 --> 00:55:30,961 >> THANK YOU. 1166 00:55:30,961 --> 00:55:34,097 >> VERY INTERESTING TALK. SO MY 1167 00:55:34,097 --> 00:55:36,767 QUESTION IS I'M THINKING THE 1168 00:55:36,767 --> 00:55:38,569 MECHANISM TO HOW INTERLEUKIN 17 1169 00:55:38,569 --> 00:55:42,139 IS GOING TO INCREASE THE 1170 00:55:42,139 --> 00:55:43,507 SOCIOIBILITY RATE. DO YOU KNOW 1171 00:55:43,507 --> 00:55:46,877 BY CHANCE WHEN YOU KNOCK OUT IL 1172 00:55:46,877 --> 00:55:49,012 17 OR RECEPTOR, THERE HAVE BEEN 1173 00:55:49,012 --> 00:55:52,249 SOME CHANGES IN THE TRANSMISSION 1174 00:55:52,249 --> 00:55:54,318 ACTIVITY? SOME CHANGES IN THE 1175 00:55:54,318 --> 00:55:56,420 NEURAL TRANSMISSION ACTIVITY 1176 00:55:56,420 --> 00:55:59,156 LIKE SOME NEURONS ESPECIALLY FOR 1177 00:55:59,156 --> 00:56:01,525 EXAMPLE SEROTONIN LEVELS SOME 1178 00:56:01,525 --> 00:56:03,861 PEOPLE THEY THINK SEROTONIN 1179 00:56:03,861 --> 00:56:09,933 LEVELS THAT WHEN THEY BECOME 1180 00:56:09,933 --> 00:56:11,001 KNOCK DOWN (INAUDIBLE) ANY OTHER 1181 00:56:11,001 --> 00:56:14,104 STUFF. AND I WAS WONDERING IL 17 1182 00:56:14,104 --> 00:56:15,806 THAT ALSO WHEN YOU INCREASE IL 1183 00:56:15,806 --> 00:56:17,874 17 THAT ALSO INCREASE OR CHANGE 1184 00:56:17,874 --> 00:56:20,911 THE LEVELS INTO THE SEROTONIN 1185 00:56:20,911 --> 00:56:22,980 ACTIVITY OR RECEPTORS OF 1186 00:56:22,980 --> 00:56:25,682 SEROTONIN CHANGED IN YOUR MODEL, 1187 00:56:25,682 --> 00:56:27,117 HOW THESE HAS BEEN CHANGED. 1188 00:56:27,117 --> 00:56:31,221 >> YEAH. SO WE THINK IL 17 A AND 1189 00:56:31,221 --> 00:56:33,523 E FUNCTION AS NEURAL MODULATOR 1190 00:56:33,523 --> 00:56:36,727 AND THEN AS TO -- VERY IMPORTANT 1191 00:56:36,727 --> 00:56:38,862 HOW THIS NEURAL MODULATOR WORK 1192 00:56:38,862 --> 00:56:42,899 BY INFLUENCING NEURAL TRANSM 1193 00:56:42,899 --> 00:56:44,268 TRANSMITTER IT IS NOT WELL UN. 1194 00:56:44,268 --> 00:56:48,939 SO WE DON'T KNOW BUT IF YOU -- I 1195 00:56:48,939 --> 00:56:52,843 OFTEN USE THIS (INAUDIBLE) 1196 00:56:52,843 --> 00:56:56,280 OXYTOCIN AS AN EXAMPLE, THOUGH 1197 00:56:56,280 --> 00:56:57,848 OXYTOCIN HAS BEEN STUDIED MANY, 1198 00:56:57,848 --> 00:57:02,486 MANY YEARS, THEY ARE -- CRITICAL 1199 00:57:02,486 --> 00:57:04,054 NEURAL MODULATOR BUT HOW THEY 1200 00:57:04,054 --> 00:57:07,057 WORK IS STILL NOT CLEAR SO TELL 1201 00:57:07,057 --> 00:57:08,692 YOU THAT UNDERSTANDING THE 1202 00:57:08,692 --> 00:57:10,594 MOLECULAR MECHANISM BY WHICH 1203 00:57:10,594 --> 00:57:11,595 NEURAL MODULATOR WORKS. 1204 00:57:11,595 --> 00:57:13,964 >> THEY DIDN'T CHECK THE LEVELS 1205 00:57:13,964 --> 00:57:16,833 IN THE KNOCK OUT MODELS? YOU 1206 00:57:16,833 --> 00:57:18,935 MENTION SOMETHING ABOUT THE 1207 00:57:18,935 --> 00:57:20,671 ACTUAL POTENTIAL HOW THAT IS 1208 00:57:20,671 --> 00:57:22,205 IMPROVED SO THAT TELL YOU HOW 1209 00:57:22,205 --> 00:57:25,542 MANY (INAUDIBLE) IS GOING ON. 1210 00:57:25,542 --> 00:57:30,814 >> COULD BE -- SO MANY, SO MANY 1211 00:57:30,814 --> 00:57:31,882 CANDIDATES WE HAVEN'T CHECKED 1212 00:57:31,882 --> 00:57:32,082 THEM. 1213 00:57:32,082 --> 00:57:33,317 >> THANK YOU. 1214 00:57:33,317 --> 00:57:34,518 >> THANK YOU VERY MUCH FOR THE 1215 00:57:34,518 --> 00:57:39,923 INTERESTING TALK. SO I HAVE A 1216 00:57:39,923 --> 00:57:42,159 QUESTION, THE SMALL MOLECULE 1217 00:57:42,159 --> 00:57:46,029 IDENTIFY FOR INHIBITING R GAMMA 1218 00:57:46,029 --> 00:57:48,532 P FUNCTION. R GAMMA P IS NOT THE 1219 00:57:48,532 --> 00:57:50,167 ONLY PH 17 SO I HAVE TWO 1220 00:57:50,167 --> 00:57:54,404 QUESTIONS BUT BASED ON THIS. THE 1221 00:57:54,404 --> 00:57:58,642 FIRST ONE IS (INAUDIBLE) LIKE RC 1222 00:57:58,642 --> 00:58:01,611 3 IL 17 IS ALSO INHIBITED AND 1223 00:58:01,611 --> 00:58:05,716 THE SECOND ONE IS R GAMMA T IS 1224 00:58:05,716 --> 00:58:09,619 ALSO EXPRESSED IN (INAUDIBLE) 1225 00:58:09,619 --> 00:58:12,122 FOR SURVIVAL OF THE CELLS SO 1226 00:58:12,122 --> 00:58:14,458 WONDERING IF YOU GIVE MORE 1227 00:58:14,458 --> 00:58:19,363 INHIBITOR MOLECULAR IF CYTOKINE 1228 00:58:19,363 --> 00:58:21,264 ALSO AFFECTED? 1229 00:58:21,264 --> 00:58:25,402 >> HAVING THE SYSTEM OURSELVES 1230 00:58:25,402 --> 00:58:27,437 PREVIOUSLY SHOW R GAMMA 1231 00:58:27,437 --> 00:58:31,108 INHIBITOR CAN ALSO SUPPRESS ILC 1232 00:58:31,108 --> 00:58:33,643 3 FUNCTION AND THEN MANY 1233 00:58:33,643 --> 00:58:36,646 (INAUDIBLE) STARTED A CLINICAL 1234 00:58:36,646 --> 00:58:38,949 TRIAL WITH INHIBITOR AND THEY 1235 00:58:38,949 --> 00:58:41,485 STOPPED THE TRIAL BECAUSE OF THE 1236 00:58:41,485 --> 00:58:43,653 DEVELOPMENT OF MELANOMA, ABOUT 1237 00:58:43,653 --> 00:58:45,956 DOUBLE IN -- THAT HAPPEN DURING 1238 00:58:45,956 --> 00:58:48,658 THE TIME SITE DEVELOPMENT SO FOR 1239 00:58:48,658 --> 00:58:51,027 R GAMMA INHIBITOR, POST DOC 1240 00:58:51,027 --> 00:58:53,497 APPOINTED CELL IN ILC 3 SEEM TO 1241 00:58:53,497 --> 00:58:56,867 BE AFFECTED BUT WHETHER OR NOT 1242 00:58:56,867 --> 00:58:58,368 THE BIAS (INAUDIBLE) INFLUENCE 1243 00:58:58,368 --> 00:58:59,503 THE SAME WE HAVEN'T TESTED THAT. 1244 00:58:59,503 --> 00:59:01,805 >> THANK YOU. 1245 00:59:01,805 --> 00:59:06,042 >> HI. SO AUTISM IS CORRELATED 1246 00:59:06,042 --> 00:59:09,813 WITH A NUMBER OF AUTOIMMUNE AND 1247 00:59:09,813 --> 00:59:11,715 ALLERGIC DISEASE INCLUDING 1248 00:59:11,715 --> 00:59:13,817 PSORIASIS WHICH IS 17 MEDIATED. 1249 00:59:13,817 --> 00:59:15,685 I'M WONDERING YOUR THOUGHTS ONE 1250 00:59:15,685 --> 00:59:17,621 ON POSSIBLE CAUSATION IN TERMS 1251 00:59:17,621 --> 00:59:19,289 OF WHY THESE MIGHT COME TOGETHER 1252 00:59:19,289 --> 00:59:21,658 BUT ALSO THIS MIGHT LIMIT 1253 00:59:21,658 --> 00:59:23,360 UTILITY OF THIS AS THERAPEUTIC. 1254 00:59:23,360 --> 00:59:26,329 IF YOU HAVE PEOPLE ALREADY 1255 00:59:26,329 --> 00:59:28,665 EXCESSIVE 17 PATHWAY. 1256 00:59:28,665 --> 00:59:31,635 >> RIGHT. I THINK PARTICULARLY 1257 00:59:31,635 --> 00:59:34,738 DURING PREGNANCY, ALLERGIC 1258 00:59:34,738 --> 00:59:36,006 RESPONSE THERE IS A PAPER 1259 00:59:36,006 --> 00:59:38,341 SHOWING THAT'S SOME CORRELATION 1260 00:59:38,341 --> 00:59:41,111 AND THEN SOME PSORIATIC PATIENT 1261 00:59:41,111 --> 00:59:43,246 HAVE DEVELOPED AWE TIM SYMPTOMS 1262 00:59:43,246 --> 00:59:45,248 SO WHETHER OR NOT -- SO WE DON'T 1263 00:59:45,248 --> 00:59:46,516 KNOW, SHORT ANSWER WE DON'T KNOW 1264 00:59:46,516 --> 00:59:48,952 BUT IN TERMS THERAPEUTICS, 1265 00:59:48,952 --> 00:59:50,120 (INAUDIBLE) INDICATED AND OTHERS 1266 00:59:50,120 --> 00:59:54,491 SHOW THAT INCREASE IL 17 ALONE 1267 00:59:54,491 --> 00:59:56,159 IS NOT -- NOT REALLY 1268 00:59:56,159 --> 00:59:59,129 INFLAMMATORY. NOT INFLAMMATORY. 1269 00:59:59,129 --> 01:00:01,364 WHEN I PRESENT WAY OTHER 1270 01:00:01,364 --> 01:00:02,899 CYTOKINES INTERFERON GAMMA 1271 01:00:02,899 --> 01:00:06,536 (INAUDIBLE) INFLAMMATION. SO I 1272 01:00:06,536 --> 01:00:10,040 THINK YOUR QUESTION THERE ARE 1273 01:00:10,040 --> 01:00:13,176 (INAUDIBLE) FIRST I DON'T KNOW, 1274 01:00:13,176 --> 01:00:14,744 SECOND MAYBE. 1275 01:00:14,744 --> 01:00:15,378 >> THANK YOU. 1276 01:00:15,378 --> 01:00:20,417 >> THAT WAS A GREAT TALK. SO THE 1277 01:00:20,417 --> 01:00:23,854 IL 17 IN RESPONSE TO INFECTION 1278 01:00:23,854 --> 01:00:26,456 OR PRESUMABLY THAT'S PERIPHERAL 1279 01:00:26,456 --> 01:00:27,724 IL 17. THAT HAS TO GO INTO THE 1280 01:00:27,724 --> 01:00:32,062 BRAIN. DOES THAT PASS THROUGH 1281 01:00:32,062 --> 01:00:33,663 BLOOD BRAIN BARRIER EASILY? 1282 01:00:33,663 --> 01:00:37,634 >> WHEN THE CYTOKINES GET 1283 01:00:37,634 --> 01:00:40,837 INDUCED IN THE CONTEXT OF 1284 01:00:40,837 --> 01:00:43,673 INFLAMMATION, THIS IS LIKE ONE 1285 01:00:43,673 --> 01:00:45,742 THING THAT FIELD PEOPLE NOTICE 1286 01:00:45,742 --> 01:00:48,678 FOR MANY, MANY YEARS BUT STILL 1287 01:00:48,678 --> 01:00:50,514 IS NOT CLEAR NOBODY UNDERSTAND 1288 01:00:50,514 --> 01:00:53,083 MOLECULAR MECHANISM WHICH IS 1289 01:00:53,083 --> 01:00:55,919 WHEN YOU GIVE MICE WITH APS 1290 01:00:55,919 --> 01:00:57,854 EXPOSE MICE WITH VIRAL INFECTION 1291 01:00:57,854 --> 01:01:00,957 THERE IS TEMPORALLY INCREASE 1292 01:01:00,957 --> 01:01:03,326 PERMEABILITY IN THE BBB. SO YOU 1293 01:01:03,326 --> 01:01:06,696 ARE INDUCING INFLAMMATION, GIVE 1294 01:01:06,696 --> 01:01:09,332 SOME TIME THEN YOUR BRAIN MOUSE 1295 01:01:09,332 --> 01:01:14,104 BRAIN IS TURN BLUE. SO THIS 1296 01:01:14,104 --> 01:01:15,105 INFLAMMATION HAS AN AMAZING 1297 01:01:15,105 --> 01:01:17,707 ABILITY TO INCREASE 1298 01:01:17,707 --> 01:01:19,342 PERMEABILITY. THAT IS A GOOD 1299 01:01:19,342 --> 01:01:22,546 REASON FOR THAT. BECAUSE THAT IS 1300 01:01:22,546 --> 01:01:26,883 WHAT THAT NEED TO HAPPEN DURING 1301 01:01:26,883 --> 01:01:29,185 INFLAMMATION WHEN INUNDATED BY 1302 01:01:29,185 --> 01:01:31,755 INFECTION. SO IN THAT CONTEXT, 1303 01:01:31,755 --> 01:01:35,625 INFLAMMATORY CONTEXT I 1304 01:01:35,625 --> 01:01:36,526 ABSOLUTELY (INAUDIBLE) IN THE 1305 01:01:36,526 --> 01:01:37,093 BRAIN MECHANISM. 1306 01:01:37,093 --> 01:01:40,830 >> LAST QUESTION. THANK YOU FOR 1307 01:01:40,830 --> 01:01:42,599 THAT TALK. THAT WAS AWESOME. SO 1308 01:01:42,599 --> 01:01:44,601 I JUST HAD A QUESTION ON THE 1309 01:01:44,601 --> 01:01:45,602 MATERNAL IMMUNE ACTIVATION 1310 01:01:45,602 --> 01:01:48,104 MODEL. WHEN YOU CHALLENGE WITH 1311 01:01:48,104 --> 01:01:50,340 POLYIC AND THEN LATER SEE AUTISM 1312 01:01:50,340 --> 01:01:52,008 PHENOTYPE MANY THE OFFSPRING, DO 1313 01:01:52,008 --> 01:01:53,577 YOU THINK THERE'S ANY 1314 01:01:53,577 --> 01:01:54,978 COMMONALITY TO THE ANTIGEN 1315 01:01:54,978 --> 01:01:57,013 RESTRICTION TO THE TH 17 CELLS 1316 01:01:57,013 --> 01:01:59,616 GENERATED IN THE OFFSPRING? 1317 01:01:59,616 --> 01:02:01,518 PERHAPS LIKE TWO POLYIC BECAUSE 1318 01:02:01,518 --> 01:02:03,954 I KNOW REACH TOUT LPSO, ANY 1319 01:02:03,954 --> 01:02:05,255 CORRELATION FOR THE ANTIGEN 1320 01:02:05,255 --> 01:02:08,158 RESEARCH OF THOSE T-CELLS? 1321 01:02:08,158 --> 01:02:14,965 >> WE DON'T KNOW. SO I MEAN, WE 1322 01:02:14,965 --> 01:02:19,636 CAN INDUCE SIMILAR PHENOTYPE BY 1323 01:02:19,636 --> 01:02:21,538 TRANSPORTING T-CELL MICE DURING 1324 01:02:21,538 --> 01:02:28,044 PREGNANCY. SO TCL NOT 1325 01:02:28,044 --> 01:02:28,979 NECESSARILY (INAUDIBLE) BUT 1326 01:02:28,979 --> 01:02:32,182 WHETHER -- WE ALSO DETECT -- 1327 01:02:32,182 --> 01:02:36,920 OFFSPRING SIDE THERE ARE SECOND 1328 01:02:36,920 --> 01:02:40,123 CHALLENGE IT BUT WHETHER OR NOT 1329 01:02:40,123 --> 01:02:43,460 THIS -- CHANGE IN TISSUE THAT 1330 01:02:43,460 --> 01:02:47,564 PUTS FORWARD -- AND THIS ISSUE 1331 01:02:47,564 --> 01:02:48,865 DIFFERENCE IMMUNE (INAUDIBLE) 1332 01:02:48,865 --> 01:02:52,669 DURING PREGNANCY CAN INDUCE 1333 01:02:52,669 --> 01:02:53,203 CHANGES IN OFF SPRIEST MT. 1334 01:02:53,203 --> 01:02:55,138 SYSTEM. SO I THINK DOSE 1335 01:02:55,138 --> 01:02:58,208 DEPENDENT ON PATHOGEN, LIKE 1336 01:02:58,208 --> 01:03:01,911 ANTIGENS, IT IT IS NOT -- 1337 01:03:01,911 --> 01:03:05,281 >> THANK YOU VERY MUCH. SO I SAW 1338 01:03:05,281 --> 01:03:08,051 THAT STORY GOT PRESENTED AS 1339 01:03:08,051 --> 01:03:10,487 SUBMITTED SO MAYBE WE CAN SEND 1340 01:03:10,487 --> 01:03:13,089 SOME FLOWERS FOR IL 17, 1341 01:03:13,089 --> 01:03:14,891 CHOCOLATE COATED WITH IL 17. 1342 01:03:14,891 --> 01:03:17,027 GOOD LUCK WITH YOUR STORY. THANK 1343 01:03:17,027 --> 01:03:18,762 YOU, EVERYONE FOR COMIN COMING 1344 01:03:18,762 --> 01:03:28,938 [APPLAUSE]